Sanofi

Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains (QIV-SD)

Phase 3

Influenza Immunization

Purified inactivated rabies vaccine, serum free

Phase 3

Rabies

clofarabine (IV formulation)

Phase 3

Acute Myelogenous Leukemia

Irbesartan/hydrochlorothiazide

Phase 3

Hypertension

sevelamer carbonate (Renvela®) sevelamer hydrochloride (Renagel ®)

Phase 3

Chronic Kidney Disease

HOE901-U300 (Insulin glargine new formulation)

Phase 3

Type 1 Diabetes Mellitus

Euvax B®: Hepatitis B vaccine

Phase 3

Hepatitis B

XRP6976

Phase 3

Stomach Neoplasm

Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virus

Phase 3

Dengue Fever

enoxaparin (XRP4563)

Phase 3

Hip Fractures

Otamixaban

Phase 3

Acute Coronary Syndrome

DTaP-HB-PRP~T vaccine + OPV

Phase 3

Diphtheria

paclitaxel

Phase 3

Uterine Carcinosarcoma

Prednisone or Prednisolone

Phase 3

Prostatic Neoplasms

Sevelamer carbonate (Renvela®)

Phase 3

Kidney Diseases

Leucovorin

Phase 3

Pancreatic Neoplasms

Pomalidomide

Phase 3

Plasma Cell Myeloma

Meningococcal polysaccharide group A, C, W-135 and Y Conjugate vaccine

Phase 3

Meningococcal Immunisation (Healthy Volunteers)

Sevelamer Hydrochloride (Renagel®)

Phase 3

Peritoneal Dialysis

Antihyperglycemic Drug

Phase 3

Hypercholesterolaemia

Metformin

Phase 3

Type 2 Diabetes Mellitus

insulin glulisine

Phase 3

Diabetes Mellitus

Thiocolchicoside+Ketoprofen

Phase 3

Low Back Pain

Yellow fever vaccine (live)

Phase 3

Yellow Fever Immunization

Riluzole

Phase 3

Huntington Disease

SENNA+CASSIA

Phase 3

Constipation

clopidogrel (SR25990C)

Phase 3

Atrial Fibrillation

High-Dose Quadrivalent Influenza Vaccine, (Zonal Purified, Split Virus) 2020-2021 Strains (QIV-HD)

Phase 3

Influenza Immunization

Fitusiran

Phase 3

Hemophilia

DTaP-HB-PRP~T vaccine

Phase 3

Diphtheria

CABAZITAXEL

Phase 3

Prostate Cancer Metastatic

DTaP-IPV-Hep B-PRP~T combined vaccine

Phase 3

Diphtheria

Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined

Phase 3

Meningitis

Duvakitug

Phase 3

Ulcerative Colitis

Warfarin

Phase 3

Embolism

Oral corticosteroid therapy (prednisone/prednisolone)

Phase 3

Asthma

ambroxol BIH1526

Phase 3

Pharyngitis

SR34006

Phase 3

Pulmonary Embolism

Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)

Phase 3

Japanese Encephalitis

carfilzomib

Phase 3

Plasma Cell Myeloma

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 3

Meningococcal Meningitis

Non-insulin antihyperglycemic drugs

Phase 3

Type 2 Diabetes Mellitus

Eliglustat tartrate

Phase 3

Gaucher Disease, Type 1

irinotecan hydrochloride

Phase 3

Colorectal Cancer

INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)

Phase 3

Type 2 Diabetes Mellitus

tolevamer potassium-sodium (GT267-004)

Phase 3

Clostridium Enterocolitis

Teplizumab

Phase 3

Type 1 Diabetes Mellitus

Inactive Poliovirus Vaccine

Phase 3

Poliomyelitis

Riliprubart Prefilled Pen (PFP)

Phase 3

Polyneuropathy, Inflammatory Demyelinating, Chronic

FEX60/PE10

Phase 3

Rhinitis Allergic

Insulin monotherapy with premixed insulin NPH 30/70

Phase 3

Diabetes Mellitus, Type 2

Topical calcineurin inhibitors

Phase 3

Dermatitis Atopic

Meningococcal polysaccharide (serogroups A,C,Y and W-135) diphtheria toxoid conjugate vaccine

Phase 3

Meningococcal Immunization

HBVAXPRO 5µg

Phase 3

Virus Diseases

escitalopram

Phase 3

Depressive Disorder

Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV)

Phase 3

Meningococcal Immunisation

SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent D614) (primary series)

Phase 3

COVID-19

Moisturizers

Phase 3

Neurodermatitis

sutimlimab (BIVV009)

Phase 3

Cold Agglutinin Disease

Antidiabetic background therapy

Phase 3

Type 2 Diabetes

Glucocorticoid

Phase 3

Immunoglobulin G4 Related Disease

PCV21 vaccine

Phase 3

Pneumococcal Immunization

Inactivated, split-virion influenza vaccine

Phase 3

Orthomyxoviridae Infection

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate vaccine)

Phase 3

Meningococcal Immunisation

Imiglucerase

Phase 3

Gaucher Disease, Type 1

Zolpidem (SL800750)

Phase 3

Attention Deficit Hyperactivity Disorder

Vandetanib (SAR390530)

Phase 3

Differentiated Thyroid Cancer

Itepekimab (SAR440340)

Phase 3

Chronic Obstructive Pulmonary Disease

Riliprubart

Phase 3

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

teriflunomide (HMR1726)

Phase 3

Multiple Sclerosis

Sarilumab

Phase 3

Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative

Phase 3

Influenza

paroxetine

Phase 3

Depressive Disorder, Major

Semuloparin Sodium

Phase 3

Venous Thromboembolism

Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib

Phase 3

Diphtheria

Meningococcal polysaccharide diphtheria toxoid conjugate

Phase 3

Meningitis

GEMIGLIPTIN LS15-0444

Phase 3

Type 2 Diabetes Mellitus

FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)

Phase 3

Colorectal Neoplasms

afuzosin

Phase 3

Benign Prostatic Hyperplasia

Fexofenadine M016455

Phase 3

Rhinitis Seasonal

Idrabiotaparinux sodium

Phase 3

Deep Venous Thrombosis

rFVIIIFc

Phase 3

Hemophilia A

LACTIC ACID(ND)

Phase 3

Hygiene

Antithrombin concentrate (ATIIIC)

Phase 3

Hemophilia

Allopurinol

Phase 3

Tumor Lysis Syndrome

BPA prophylaxis

Phase 3

Hemophilia

Insulin human/Insuman Comb 25 (HR1799)

Phase 3

Type 2 Diabetes Mellitus

RSVt vaccine

Phase 3

RSV Immunization

SR123781A

Phase 3

Venous Thromboembolism

Doxorubicine + docetaxel sequential

Phase 3

Breast Neoplasms

Influenza Virus Vaccine USP Trivalent Types A and B

Phase 3

Orthomyxoviridae Infection

DTaP-IPV-Hep B- PRP~T + Prevenar + Rotarix vaccine

Phase 3

Diphtheria

Sulfonylurea

Phase 3

Type 2 Diabetes Mellitus

Quadrivalent Influenza Vaccine (split virion, inactivated)

Phase 3

Influenza

Oxaliplatin + 5-Fluorouracil/Leucovorin

Phase 3

Carcinoma, Hepatocellular

Investigational Quadrivalent Inactivated Influenza Vaccine, No Preservative

Phase 3

Influenza

DTaP-IPV combined vaccine

Phase 3

Pertussis

SENNA+CASSIA(Naturetti)

Phase 3

Constipation

FluCAM [Fludara + Campath]

Phase 3

B-Cell Chronic Lymphocytic Leukemia

paracetamol 4.8% paediatric oral suspension

Phase 3

Fever

DTaP-HB PRP~T Combined Vaccine

Phase 3

Diphtheria

Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)

Phase 3

Hygiene

NPH human insulin

Phase 3

Diabetes Mellitus, Type 2

Insulin glargine U300 (new formulation of insulin glargine) HOE901

Phase 3

Diabetes Mellitus Type 2

FluBlok®

Phase 3

Influenza

Insulin glargine (HOE901)

Phase 3

Type 2 Diabetes Mellitus

Measles, combinations with mumps and rubella, live attenuated

Phase 3

Yellow Fever Immunization

Pneumo 23

Phase 3

Streptococcus Pneumoniae

CELIVARONE (SSR149744C)

Phase 3

Atrial Fibrillation

amiodarone

Phase 3

Atrial Fibrillation

Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus

Phase 3

Dengue Fever

Atorvastatin

Phase 3

Hypercholesterolemia

Thyrogen (thyrotropin alfa for injection)

Phase 3

Differentiated Thyroid Cancer

Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid)

Phase 3

Hygiene

Exenatide

Phase 3

Diabetes Mellitus, Type 2

Glutamine

Phase 3

Colorectal Neoplasms

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL)

Phase 3

Diphtheria

Cholestyramine

Phase 3

Multiple Sclerosis

Prevnar 20 vaccine

Phase 3

Pneumococcal Immunization

Doxorubicin

Phase 3

Breast Neoplasms

rFIXFc

Phase 3

Hemophilia B

Humalog

Phase 3

Type 1 Diabetes Mellitus

Docetaxel, Cisplatin, 5-fluorouracil (5-FU), radiotherapy

Phase 3

Head and Neck Neoplasms

Live, attenuated, dengue serotype 1, 2, 3, 4 virus

Phase 3

Dengue

Sitagliptin

Phase 3

Diabetes Mellitus, Type 2

Teriflunomide HMR1726

Phase 3

Relapsing Multiple Sclerosis

Cyclophosphamide

Phase 3

Breast Neoplasms

Alirocumab SAR236553

Phase 3

Hypercholesterolaemia

CYD Dengue vaccine

Phase 3

Dengue Fever

Teriflunomide

Phase 3

Multiple Sclerosis

Meningococcal polysaccharide groups A, C, W-135 and Y Conjugate vaccine

Phase 3

Meningitis

JE-VAX®

Phase 3

Japanese Encephalitis

Avalglucosidase alfa (GZ402666)

Phase 3

Glycogen Storage Disease Type II;Pompe's Disease

aflibercept

Phase 3

Colorectal Neoplasms

Corticosteroids

Phase 3

Thrombotic Thrombocytopenic Purpura

Concomitant administration

Phase 3

Diphtheria

Diphteria, tetanus, and Acellular Pertussis vaccine

Phase 3

Diphtheria

Isatuximab SAR650984

Phase 3

Multiple Myeloma

M-M-R II vaccine

Phase 3

Pneumococcal Immunization

docetaxel, doxorubicin, cyclophosphamide

Phase 3

Breast Cancer

JE-CV Vaccine

Phase 3

Japanese Encephalitis

Bortezomib

Phase 3

Plasma Cell Myeloma

Insulin glargine,300 U/mL

Phase 3

Type 1 Diabetes Mellitus

Meningococcal Group C Conjugate vaccine: MenC

Phase 3

Meningitis

S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + 5-chloro-2, 4-dihydroxypyridine (CDHP) (Gimeracil) + Oxo (Oteracil)

Phase 3

Gastric Cancer

Influenza Virus Vaccine

Phase 3

Influenza

Purified vero rabies vaccine - serum free VRVg-2

Phase 3

Rabies (Healthy Volunteers)

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

Phase 3

Cholera

QIV-HD

Phase 3

Influenza

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine

Phase 3

Meningitis

DTaP-IPV-HB-PRP~T vaccine

Phase 3

Diphtheria

Spores of Bacillus Clausii Probiotic Strain

Phase 3

Diarrhea

REPEVAX

Phase 3

Healthy

Alirocumab

Phase 3

Hypercholesterolemia

PEDIACEL® and Prevenar®

Phase 3

Diphtheria

Oral anti-diabetic drugs

Phase 3

Type 2 Diabetes Mellitus

Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed

Phase 3

Tetanus

Oxaliplatin

Phase 3

Carcinoma, Hepatocellular

ZD6474 (vandetanib)

Phase 3

Thyroid Cancer

Live, attenuated dengue serotype 1, 2, 3, and 4 virus

Phase 3

Dengue

SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1

Phase 3

COVID-19

omega-3 polyunsaturated fatty acids (PUFA)

Phase 3

Diabetes Mellitus, Non-Insulin-Dependent

acetylsalicyclic acid (ASA)

Phase 3

Acute Coronary Disease

Hexaxim®

Phase 3

Diphtheria

High-Dose Quadrivalent Influenza Vaccine

Phase 3

Influenza (Healthy Volunteers)

Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 3

Meningitis

gemcitabine/Eloxatin (GEMOX)

Phase 3

Carcinoma, Non-Small-Cell Lung

Non sedating H1-antihistamine

Phase 3

Cold Urticaria

Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus

Phase 3

Tetanus

Meningococcal Diphtheria Toxoid Vaccine

Phase 3

Meningitis

Insulin glargine (U300)

Phase 3

Type 2 Diabetes Mellitus

Alfuzosin

Phase 3

Acute Urinary Retention

Tocilizumab

Phase 3

Rheumatoid Arthritis

Budesonide

Phase 3

Chronic Rhinosinusitis With Nasal Polyps

enoxaparin

Phase 3

Abdominal Neoplasms

HDCV

Phase 3

Healthy Volunteers (Rabies Immunization)

High-Dose trivalent influenza vaccine (Split virion, Inactivated)

Phase 3

Influenza

Docetaxel/DDP

Phase 3

Lung Neoplasms

SAR153191 (REGN88)

Phase 3

Rheumatoid Arthritis

PVRV

Phase 3

Rabies

Insulin aspart

Phase 3

Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus

DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus)

Phase 3

Pertussis Immunisation

Japanese encephalitis vaccine

Phase 3

Japanese Encephalitis

Caplacizumab (ALX-0081)

Phase 3

Thrombotic Thrombocytopenic Purpura

ChimeriVax™-JE

Phase 3

Japanese Encephalitis

Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant.

Phase 3

Dengue Fever

Inhaled Long-Acting Beta Agonist

Phase 3

Chronic Obstructive Pulmonary Disease

Saredutant (SR48968C)

Phase 3

Depressive Disorder

Fluorouracil

Phase 3

Colorectal Cancer Metastatic

Quadrivalent Recombinant influenza vaccine (RIV4) season/2022-2023/NH

Phase 3

Influenza Immunization

IVIg

Phase 3

Chronic Inflammatory Demyelinating Polyneuropathy

Alemtuzumab 12 mg

Phase 3

Multiple Sclerosis, Relapsing-Remitting

saredutant (SR48968)

Phase 3

Major Depressive Disorder

Bacillus Clausii

Phase 3

Gastroenteritis

Capecitabine

Phase 3

Stomach Neoplasms

Amlitelimab

Phase 3

Dermatitis Atopic

DTaP//PRP-T Combined Vaccine

Phase 3

Diphtheria

Hexavalent vaccine

Phase 3

Neisseria Meningitidis

Prednisone

Phase 3

Chronic Graft Versus Host Disease

Rosuvastatin

Phase 3

Hypercholesterolemia

Dermacyd Breeze Pocket BR (Lactic Acid)

Phase 3

Hygiene

IMOJEV

Phase 3

Japanese Encephalitis

sodium hyaluronate

Phase 3

Osteoarthritis of Shoulder

High-Dose Inactivated, Split-Virion Influenza Vaccine

Phase 3

Orthomyxoviridae Infection

zolpidem-MR (modified release)

Phase 3

Sleep Initiation and Maintenance Disorders

Tritanrix-HepB/Hib

Phase 3

Diphtheria

riferminogene pecaplasmid

Phase 3

Peripheral Vascular Diseases

Live attenuated Japanese encephalitis chimeric virus vaccine

Phase 3

Japanese Encephalitis

Quadrivalent Influenza Vaccine

Phase 3

Influenza

Iniparib (SAR240550/BSI-201)

Phase 3

Solid Tumors

dianicline

Phase 3

Smoking

Insulin glargine (HOE901) (Lantus)

Phase 3

Type 1 Diabetes Mellitus

FDC KETOPROFEN+OMEPRAZOLE

Phase 3

Pain

Clotting factor concentrates (CFC) or bypassing agents (BPA)

Phase 3

Hemophilia

Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®

Phase 3

Diphtheria

Aldurazyme

Phase 3

Mucopolysaccharidosis I

DAPTACEL®. (DTaP), IPOL®., and ActHIB®.

Phase 3

Diphtheria

Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine

Phase 3

Neisseria Meningitidis

Levofloxacin

Phase 3

Prostatitis

Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis)

Phase 3

Tetanus

xaliproden (SR57746A)

Phase 3

Alzheimer Disease

Triamcinolone

Phase 3

Rhinitis, Allergic, Perennial

Glycerine Vegetal Soap Granado Traditional

Phase 3

Hygiene

sevelamer carbonate 800mg

Phase 3

Renal Failure Chronic

Asthma Controller Therapies

Phase 3

Asthma

Ciclesonide (XRP1526)

Phase 3

Asthma

Interferon beta-1a

Phase 3

Multiple Sclerosis, Relapsing-Remitting

larotaxel (RPR109881, XRP9881)

Phase 3

Breast Cancer

larotaxel (XRP9881)

Phase 3

Advanced Breast Cancer

Venglustat (GZ402671)

Phase 3

Fabry Disease

Asthma Controller Therapies (include prednisone/prednisolone)

Phase 3

Asthma

triamcinolone XRG5029

Phase 3

Rhinitis Allergic

lormetazepam

Phase 3

Sleep Initiation and Maintenance Disorders

MAXOMAT ®, biosynthetic growth hormone

Phase 3

Noonan Syndrome

5-fluorouracil

Phase 3

Breast Cancer

Quadrivalent Recombinant Influenza Vaccine (RIV4)

Phase 3

Influenza (Healthy Volunteers)

Non-statin LMT

Phase 3

Hypercholesterolemia

SGLT2 inhibitor

Phase 3

Type 2 Diabetes Mellitus

DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)

Phase 3

Diphtheria

Erlotinib

Phase 3

Non Small Cell Lung Cancer

Quadrivalent influenza vaccine (QIV) (split virion, inactivated) Northern Hemisphere (NH) 2015-2016

Phase 3

Influenza

insulin secretagogue

Phase 3

Diabetes Mellitus, Type 2

alemtuzumab

Phase 3

B Cell Chronic Lymphocytic Leukemia

hydroxychloroquine (Z0188)

Phase 3

Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus

DTaP-IPV//PRP~T combined vaccine

Phase 3

Diphtheria

Sulfasalazine

Phase 3

Rheumatoid Arthritis

Infanrix® -IPV+Hib

Phase 3

Pertussis

Caplacizumab

Phase 3

Acquired Thrombotic Thrombocytopenic Purpura

Telithromycin (HMR3647)

Phase 3

Pneumonia

Ombrabulin (AVE8062)

Phase 3

Ovarian Cancer Recurrent

Topical corticosteroids

Phase 3

Dermatitis Atopic

lunsekimig

Phase 3

Chronic Rhinosinusitis With Nasal Polyps

Insulin Aspart SAR341402

Phase 3

Type 1 Diabetes Mellitus

Granulocyte-colony stimulating factor (G-CSF)

Phase 3

Non-Hodgkin's Lymphoma

Plerixafor

Phase 3

Multiple Myeloma

volinanserin (M100907)

Phase 3

Sleep Initiation and Maintenance Disorders

Azithromycin

Phase 3

Lung Transplant Rejection

HBVaxPRO® 5 µg / 0.5 mL

Phase 3

Hepatitis B

Pemetrexed

Phase 3

Non Small Cell Lung Cancer

BIVV009

Phase 3

Agglutinin Disease, Cold

irbesartan/amlodipine

Phase 3

Hypertension

Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine

Phase 3

Meningococcal Immunisation (Healthy Volunteers)

eplivanserin (SR46349)

Phase 3

Sleep Initiation and Maintenance Disorders

Lipid Modifying Therapy (LMT)

Phase 3

Hypercholesterolemia

SR121463B

Phase 3

Inappropriate ADH Syndrome

Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus

Phase 3

Dengue

Clopidogrel

Phase 3

Thrombosis

PCV21

Phase 3

Pneumococcal Infections

epidoxorubicine, ciclophosphamide, methotrexate, fluorouracile

Phase 3

Breast Neoplasms

Low Dose (LD) RSVt vaccine

Phase 3

RSV Immunisation

Lactic acid (Dermacid)

Phase 3

Healthy

Dermacyd PH_DETINLYN (Lactic Acid)

Phase 3

Hygiene

Influenza virus vaccine (split virion, inactivated)

Phase 3

Influenza

MenACYW conjugate vaccine

Phase 3

Meningococcal Infections

Rilzabrutinib

Phase 3

Immune Thrombocytopenia

Typhoid Vi polysaccharide

Phase 3

Salmonella Infections

ketoprofen 100 mg

Phase 3

Pain

risedronate (HMR4003)

Phase 3

Osteoporosis, Postmenopausal

Enoxaparin sodium

Phase 3

Venous Thromboembolism

Diphtheria, tetanus, polio and pertussis vaccination

Phase 3

Diphtheria

REVAXIS®

Phase 3

Diphtheria

Mometasone furoate nasal spray (MFNS)

Phase 3

Chronic Rhinosinusitis With Nasal Polyps

Purified vero rabies vaccine - serum free - VRVg-2

Phase 3

Rabies

Lantus (Insulin glargine)

Phase 3

Type 2 Diabetes Mellitus

Dupilumab SAR231893 (REGN668)

Phase 3

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

Insulin glargine

Phase 3

Diabetes Mellitus, Type 1

Ezetimibe

Phase 3

Hypercholesterolemia

fexofenadine/Allegra (M016455)

Phase 3

Atopic Dermatitis

NPH insulin

Phase 3

Type 1 Diabetes Mellitus

Insulin glargine/lixisenatide fixed ratio combination

Phase 3

Type 2 Diabetes Mellitus

Cetylpyridinium chloride

Phase 3

Hygiene

DTaP-IPV-Hep B-PRP~T combined vaccine + Pneumococcal polysaccharide

Phase 3

Diphtheria

zolpidem-MR (SL800750)

Phase 3

Sleep Initiation and Maintenance Disorders

Dupilumab

Phase 3

Lichen Simplex Chronicus

Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine

Phase 3

Diphtheria

ChimeriVax-JE, Japanese Encephalitis vaccine

Phase 3

Encephalitis

REPEVAX® after REVAXIS®

Phase 3

Healthy Adult

CombAct-HIB®

Phase 3

Hepatitis B

Alfuzosin (SL770499)

Phase 3

Urinary Retention

Pioglitazone

Phase 3

Diabetes Mellitus Type 2

volinanserin

Phase 3

Sleep Initiation and Maintenance Disorders

DOCETAXEL(XRP6976) + MODAFINIL

Phase 3

Prostatic Neoplasms

clopidogrel (SR25990)

Phase 3

Stable Angina

vinorelbine tartrate

Phase 3

Lung Cancer

Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant

Phase 3

Dengue Fever

Irinotecan

Phase 3

Carcinoma, Non-Small-Cell Lung

avalglucosidase alfa

Phase 3

Glycogen Storage Disease Type II

Lantus (insulin glargine [rDNA origin] injection)

Phase 3

Diabetes Mellitus

Lactic acid (Dermacyd Femina)

Phase 3

Hygiene

Frexalimab

Phase 3

Type 1 Diabetes Mellitus

XRP6976 (Docetaxel/Taxotere)

Phase 3

Cancer

Glimepiride and Metformin hydrochloride combination (HOE490)

Phase 3

Type 2 Diabetes Mellitus

Low to medium potent topical corticosteroids

Phase 3

Neurodermatitis

Diphteria/Tetanus/Polio/Acellular Pertussis/Hib vaccine

Phase 3

Diphtheria

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower

Phase 3

Hygiene

Fexofenadine

Phase 3

Seasonal Allergic Rhinitis

SR58611A

Phase 3

Anxiety Disorders

Lixisenatide (AVE0010)

Phase 3

Diabetes Mellitus, Type 2

Tirapazamine

Phase 3

Head and Neck Squamous Cell Carcinoma

Isatuximab IV

Phase 3

Plasma Cell Myeloma Recurrent

Generic = Plerixafor

Phase 3

Lymphoma (Non-Hodgkin's Lymphoma)

amlodipine

Phase 3

Hypertension

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®)

Phase 3

Meningitis

DAPTACEL®: DTaP

Phase 3

Diphtheria

Dermacyd PH_DETINBACK (Lactic Acid)

Phase 3

Hygiene

Granulocyte colony-stimulating factor plus plerixafor

Phase 3

Lymphoma, Non-Hodgkin

Piperacillin/Tazobactam

Phase 3

Pneumonia

MenACYW-135 conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Multi-dose Quadrivalent Influenza Vaccine

Phase 3

Influenza

Saredutant

Phase 3

Generalized Anxiety

Irbesartan/Amlodipine (150/5mg)

Phase 3

Hypertension

Docetaxel (XRP6976)

Phase 3

Prostate Cancer

Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)

Phase 3

Healthy Volunteers (Meningococcal Infection)

Methotrexate

Phase 3

Uveitis

Folic acid

Phase 3

Rheumatoid Arthritis

Mometasone furoate nasal spray

Phase 3

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate

Phase 3

Meningitis

Tolebrutinib

Phase 3

Primary Progressive Multiple Sclerosis

Glimepiride+metformin (Amaryl M®) - HOE4900

Phase 3

Type 2 Diabetes Mellitus

Leflunomide

Phase 3

Systemic Lupus Eythematosus (SLE)

Inactivated Poliomyelitis vaccine

Phase 3

Poliomyelitis

SR57746A

Phase 3

Metastases

glimepiride

Phase 3

Type 2 Diabetes Mellitus

DTaP-IPV-Hep B-PRP-T Vaccine

Phase 3

Diphtheria

rimonabant

Phase 3

Smoking Cessation

VRVg-2

Phase 3

Rabies (Healthy Volunteers)

HOE901-U300 (new formulation of insulin glargine)

Phase 3

Type 2 Diabetes Mellitus

Basal Insulin

Phase 3

Diabetes Mellitus, Type 2

AVE7688

Phase 3

Hypertension

cisplatin

Phase 3

Nasopharyngeal Neoplasms

DTaP-IPV/Hib Combined vaccine

Phase 3

Tetanus

Purified vero rabies vaccine - serum free

Phase 3

Rabies (Healthy Volunteers)

Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus

Phase 3

Japanese Encephalitis

DTaP-IPV-HB-PRP~T and Pneumococcal polysaccharide vaccines

Phase 3

Hepatitis B

Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

AFLIBERCEPT AVE0005

Phase 3

Colorectal Cancer Metastatic

TdcP-IPV vaccine

Phase 3

Diphtheria

pristinamycin

Phase 3

Tonsillitis

KETOPROFEN(RP19583)

Phase 3

Pain

5-fluorouracil (5-FU)

Phase 3

Head and Neck Neoplasms

Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine

Phase 3

Meningococcal Infection

DTaP IPV HB PRP~T vaccine

Phase 3

Diphtheria

Neutral Protamine Hagedorn (NPH) insulin

Phase 3

Type 1 Diabetes Mellitus

Telithromycin

Phase 3

Maxillary Sinusitis

Dronedarone (SR33589)

Phase 3

Atrial Fibrillation

fexofenadine HCL (M016455)

Phase 3

Rhinitis Seasonal

Simvastatin

Phase 3

Hypercholesterolemia

Eplivanserin

Phase 3

Sleep Initiation and Maintenance Disorders

SanOrg34006

Phase 3

Deep Vein Thrombosis

20vPCV licensed vaccine

Phase 3

Pneumococcal Immunization

Measles-mumps-rubella-varicella vaccine

Phase 3

Meningococcal Meningitis

PENTAXIM™: DTacP IPV//PRP~T combined vaccine

Phase 3

Diphtheria

Sevelamer Carbonate (GZ419831)

Phase 3

Hyperphosphatemia

amibegron (SR58611A)

Phase 3

Major Depressive Disorders

hydroxychloroquine

Phase 3

Rheumatoid Arthritis

rimonabant (SR141716)

Phase 3

Obesity

Meningococcal Polysaccharide Diphtheria Conjugate Vaccine

Phase 3

Meningococcal Meningitis

SODIUM DIVALPROATE

Phase 3

Bipolar Disorder

Vandetanib

Phase 3

Non-small Cell Lung Cancer

SR34006 (idraparinux sodium) Injection

Phase 3

Pulmonary Embolism

Dermacid Silver (Lactic acid)

Phase 3

Hygiene

MenACYW135 polysaccharide vaccine

Phase 3

Meningococcal Infection

Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

Phase 3

Meningitis

Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation

Phase 3

Influenza

Fexofenadine (loratadine if not available)

Phase 3

Pruritus

gemcitabine/carboplatin

Phase 3

Squamous Cell Lung Cancer

gemcitabine

Phase 3

Non-small Cell Lung Cancer Stage IV

Satavaptan

Phase 3

Ascites

Sevelamer carbonate

Phase 3

Chronic Kidney Disease

SAR342434

Phase 3

Type 2 Diabetes Mellitus

alglucosidase alfa

Phase 3

Pompe Disease (Late-onset)

HUMAN INSULIN (BIOSYNTHETIC)

Phase 3

Diabetes Mellitus, Type 1

somatropine

Phase 3

Growth Hormone Deficiency

ticlopidine

Phase 3

Peripheral Arterial Disease (PAD)

Sarilumab SAR153191 (REGN88)

Phase 3

Juvenile Idiopathic Arthritis

Oxaliplatin (SR96669)

Phase 3

Colonic Neoplasms

ARTESUNATE + AMODIAQUINE

Phase 3

Malaria

Japanese encephalitis chimeric virus vaccine (JE-CV)

Phase 3

Encephalitis

risedronate

Phase 3

Osteoporosis

MMR

Phase 3

Meningitis, Meningococcal

Inhaled corticosteroid (ICS) therapy

Phase 3

Asthma

Adacel® (Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis)

Phase 3

Diphtheria

ciclesonide

Phase 3

Asthma

DTaP-HB-PRP~T combined vaccine

Phase 3

Diphtheria

Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

Phase 3

Pulmonary Diseases

Insuline Glulisine

Phase 3

Diabetes Mellitus, Type 1

DTaP-IPV-Hep B-PRP~T vaccine (Batch 1)

Phase 3

Diphtheria

Trivalent Influenza Vaccine 1 SP Shz TIV1

Phase 3

Influenza

Alirocumab SAR236553 (REGN727)

Phase 3

Hypercholesterolaemia

2011 to 2012 Trivalent Influenza Vaccine

Phase 3

Influenza

Lipid-Modifying Therapy (LMT)

Phase 3

Hypercholesterolemia

A/H1N1 pandemic influenza vaccine (non- adjuvanted)

Phase 3

Influenza

Glimepiride (HOE490)

Phase 3

Type 2 Diabetes Mellitus

75% insulin lispro protamine suspension and 25 % insulin lispro injection

Phase 3

Diabetes Mellitus, Type 2

DTaP-IPV//PRP~T combined

Phase 3

Hepatitis B

Insulin glargine/Lixisenatide

Phase 3

Type 2 Diabetes Mellitus

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®

Phase 3

Meningitis

tirapazamine (SR259075)

Phase 3

Head and Neck Neoplasms

efanesoctocog alfa (BIVV001)

Phase 3

Hemophilia A

Insulin glulisine (HMR1964)

Phase 3

Diabetes, Type I

Belumosudil

Phase 3

Chronic Graft Versus Host Disease

Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

Phase 3

Mucopolysaccharidosis I

Insulin glargine new formulation (HOE901)

Phase 3

Type 2 Diabetes Mellitus

Lactic acid (Dermacyd Femina Delicata)

Phase 3

Hygiene

Myozyme

Phase 3

Pompe Disease (Late-onset)

Topical tacrolimus or pimecrolimus

Phase 3

Dermatitis Atopic

INSULIN GLARGINE/LIXISENATIDE HOE901/AVE0010

Phase 3

Type 2 Diabetes Mellitus

sutimlimab

Phase 3

Cold Agglutinin Disease

Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine

Phase 3

Diphtheria

Ramipril

Phase 3

Myocardial Ischemia

GZ/SAR402671

Phase 2

Fabry Disease

XRP0038 (NV1FGF)

Phase 2

Peripheral Arterial Disease

CYD dengue vaccine serotypes (1, 2, 3, 4).

Phase 2

Dengue Virus

G-CSF Plus Plerixafor

Phase 2

Hodgkin's Disease

SAR443122

Phase 2

Colitis Ulcerative

RSV vaccine candidate

Phase 2

Respiratory Syncytial Virus Infection

SAR441344 IV

Phase 2

Systemic Lupus Erythematosus

Belumosudil 200 mg QD

Phase 2

Chronic Graft-versus-host-disease

A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®)

Phase 2

Meningitis

Oxaliplatin, Paclitaxel

Phase 2

Neoplasms, Germ Cell and Embryonal

oxaliplatine / gemcitabine / Vinorelbine

Phase 2

Non Small Cell Lung Cancer

Cabazitaxel XRP6258

Phase 2

Prostate Cancer

Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate

Phase 2

Meningitis

INIPARIB + irinotecan

Phase 2

Estrogen Receptor Negative (ER-Negative) Breast Cancer

Sevelamer hydrochloride

Phase 2

Chronic Kidney Disease

Fludarabine Phosphate (Fludara)

Phase 2

Lymphoma

HP184

Phase 2

Spinal Cord Injury

Thymoglobulin

Phase 2

Liver Dysfunction

Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus

Phase 2

Dengue Fever

Inactivated types 1, 2, and 3 poliovirus, D antigens

Phase 2

Poliomyelitis

AVE1625

Phase 2

Alzheimer Disease

SAR100842

Phase 2

Systemic Sclerosis

SAR445877

Phase 2

Solid Tumor

Clostridium difficile toxoid vaccine with adjuvant

Phase 2

Diarrhea

Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus

Phase 2

Dengue

Monovalent Subvirion A/H1N1 Influenza vaccine

Phase 2

Influenza

Artefenomel (OZ439)

Phase 2

Plasmodium Falciparum Infection

Docetaxel (Taxotere®)

Phase 2

Ovarian Cancer

FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid

Phase 2

Colorectal

Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 2

Meningococcal Meningitis

SSR150106

Phase 2

Rheumatoid Arthritis

A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine

Phase 2

Influenza

Glatiramer Acetate (GA)

Phase 2

Multiple Sclerosis

SAR444200

Phase 2

Neoplasm

SAR161271

Phase 2

Type 1 Diabetes Mellitus

docetaxel and carboplatin

Phase 2

Lung Neoplasms

Chlamydia mRNA Vaccine

Phase 2

Chlamydia Trachomatis Immunization

Inactivated, split-virion influenza virus

Phase 2

Influenza

Pneumococcal Conjugate Vaccine formulation 1

Phase 2

Pneumococcal Immunisation

surinabant (SR147778)

Phase 2

Smoking Cessation

Fixed-dose combination of capecitabine and cyclophosphamide SAR439281

Phase 2

Breast Cancer Metastatic

XL147 (SAR245408)

Phase 2

Endometrial Cancer

Rasburicase (SR29142)

Phase 2

Hyperuricemia

Allogeneic DCs and Autologous RCC Tumor Derived Cells

Phase 2

Carcinoma, Renal Cell

QIV-HD by IM

Phase 2

Influenza

Interferon-β-1

Phase 2

Multiple Sclerosis

Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate

Phase 2

Meningitis

Alemtuzumab plus Fludarabine

Phase 2

Leukemia, Lymphocytic, Chronic, B-Cell

Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine

Phase 2

Meningitis

Brivekimig

Phase 2

Hidradenitis Suppurativa

Panblok + MF59 Dose 1

Phase 2

Influenza

XL765 (SAR245409)

Phase 2

Breast Cancer

AVE5530

Phase 2

Hypercholesterolemia

SAR3419

Phase 2

Diffuse Large B-Cell Lymphoma

Inactivated Poliomyelitis vaccine (IMOVAX)

Phase 2

Poliomyelitis

HOE140 Icatibant

Phase 2

Joint Disease

SAR407899

Phase 2

Erectile Dysfunction

High-Dose Trivalent Inactivated Influenza Vaccine

Phase 2

Influenza

Quadrivalent Influenza mRNA Vaccine MRT5407

Phase 2

Influenza Immunization

Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)

Phase 2

Influenza

Iniparib

Phase 2

Primary Peritoneal Cancer

ALX-0081

Phase 2

Unstable Angina

Celivarone

Phase 2

Arrhythmia Prophylaxis

ataciguat (HMR1766)

Phase 2

Intermittent Claudication

Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28)

Phase 2

Japanese Encephalitis

Acne mRNA vaccine

Phase 2

Acne

Dupilumab SAR231893/REGN668

Phase 2

Asthma

PRN473 (SAR444727)

Phase 2

Atopic Dermatitis

Docetaxel, cisplatin and 5-FU treatment followed by concomitant cisplatin, 5-FU and radiotherapy

Phase 2

Head and Neck Neoplasms

CYD Dengue Vaccine (5 dose formulation)

Phase 2

Dengue Fever

ferroquine (SSR97193)

Phase 2

Malaria

Pneumococcal Conjugate Vaccine - formulation 1-SP0202-IIb

Phase 2

Pneumococcal Immunization

Clostridium difficile Toxoid Vaccine

Phase 2

Clostridium Difficile Infection

plerixafor GZ316455

Phase 2

Multiple Myeloma

Vandetanib 300mg

Phase 2

Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma

teplizumab 1 mg/mL

Phase 2

Diabetes Mellitus, Type 1

MRrhTSH

Phase 2

Multinodular Goiter

ALX-0171

Phase 2

Respiratory Syncytial Virus Infection

Docetaxel and cisplatin followed by gemcitabine

Phase 2

Carcinoma, Non-Small-Cell Lung

SAR444336

Phase 2

Microscopic Colitis

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 2

Meningitis

Live attenuated Japanese encephalitis virus, then ChimeriVax diluent

Phase 2

Encephalitis

SAR245408

Phase 2

Neoplasm Malignant

SSR149744C

Phase 2

Arrhythmia

SR57667B

Phase 2

Alzheimer Disease

SAR446597

Phase 2

Geographic Atrophy

DOCETAXEL(XRP6976)

Phase 2

Head and Neck Neoplasms

SL77.0499-10 (alfuzosin hydrochloride)

Phase 2

Benign Prostatic Hyperplasia

SAR425899

Phase 2

Type 2 Diabetes Mellitus

SAR447537

Phase 2

Alpha 1-Antitrypsin Deficiency

SAR441566

Phase 2

Crohn's Disease

SAR441344

Phase 2

Sjögren's Syndrome

BSI-201

Phase 2

Ovarian Cancer

Fabrazyme (agalsidase beta)

Phase 2

Fabry Disease

Influenza virus vaccine - cell based (2007-2008 Formulation)

Phase 2

Influenza

SSR240600C

Phase 2

Overactive Bladder

ChimeriVax-WN02 vaccine

Phase 2

West Nile Fever

Best Supportive Care

Phase 2

Carcinoma, Hepatocellular

Chimeric dengue serotype (1, 2, 3, 4)

Phase 2

Dengue

clofarabine

Phase 2

Acute Lymphoblastic Leukemia

Live attenuated Japanese encephalitis virus; Yellow fever virus

Phase 2

Japanese Encephalitis

larotaxel

Phase 2

Breast Cancer

Isatuximab

Phase 2

Plasma Cell Myeloma Refractory

ZD6474

Phase 2

Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

ALX-0061

Phase 2

Lupus Erythematosus, Systemic

VEGF-receptor tyrosine kinase (KDR)

Phase 2

Multiple Myeloma

High-dose quadrivalent influenza virus vaccine

Phase 2

Influenza

Swine A/H1N1 influenza vaccine (split virion, inactivated)

Phase 2

Influenza

ATN-103 10 mg q4wks

Phase 2

Rheumatoid Arthritis

A/H5N1 inactivated, split-virion influenza virus

Phase 2

Influenza

Belumosudil (KD025)

Phase 2

Graft vs Host Disease

SSR411298

Phase 2

Major Depressive Disorder

Quadrivalent Influenza mRNA Vaccine MRT5421

Phase 2

Influenza Immunization

Live attenuated Japanese encephalitis virus

Phase 2

Japanese Encephalitis

GT160-246

Phase 2

Clostridium Difficile-Associated Diarrhea

Mitoguazone

Phase 2

Lymphoma, Non-Hodgkin

FOLFIRI

Phase 2

Colorectal Cancer

ATN-103

Phase 2

Rheumatoid Arthritis

SAR446268

Phase 2

Myotonic Dystrophy

RSV vaccine formulation 1

Phase 2

Respiratory Syncytial Virus Infection

ZD1839

Phase 2

Carcinoma, Non-Small-Cell Lung

Sotagliflozin (SAR439954)

Phase 2

Diabetes Mellitus

High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)

Phase 2

Influenza

Vasopressin V2 Receptor Antagonist

Phase 2

Chronic Heart Failure

Cemiplimab REGN2810

Phase 2

Plasma Cell Myeloma

IIV-HD

Phase 2

COVID-19 Immunization

GZ389988

Phase 2

Osteoarthritis

satavaptan (SR121463B)

Phase 2

Ascites

Yellow fever vaccine (produced on serum-free Vero cells)

Phase 2

Yellow Fever

Pandemic flu H5 HA mRNA SD2 vaccine

Phase 2

Pandemic Influenza Immunization

Docetaxel and Gemcitabine

Phase 2

Non-small Cell Lung Cancer

Trilostane

Phase 2

Prostate Cancer

fresolimumab

Phase 2

Primary Focal Segmental Glomerulosclerosis

Fetal porcine cells, Neurocell-PD

Phase 2

Parkinson's Disease

SAR156597

Phase 2

Idiopathic Pulmonary Fibrosis

Docetaxel + CDDP

Phase 2

Carcinoma, Squamous Cell

unfractionated heparin

Phase 2

Coronary Disease

Inactivated, split-virion, influenza vaccine

Phase 2

Influenza

Split, Inactivated, Trivalent Influenza Vaccine

Phase 2

Orthomyxoviridae Infection

Tesevatinib

Phase 2

Autosomal Dominant Polycystic Kidney

ALX-0171 3.0 mg/kg

Phase 2

Respiratory Syncytial Virus Lower Respiratory Tract Infection

RIV (recombinant influenza vaccine)

Phase 2

COVID-19 Immunization

Isatuximab intravenous (IV)

Phase 2

Plasma Cell Myeloma

SL650472, Clopidogrel

Phase 2

Intermittent Claudication

AVE0657

Phase 2

Sleep Apnea, Obstructive

Quadrivalent Inactivated Influenza High Dose

Phase 2

Influenza Immunization

Short-Acting Beta Agonists (SABA)

Phase 2

Asthma

Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC

Phase 2

Diphtheria

Zemaira

Phase 2

Alpha 1-Antitrypsin Deficiency

Oxaliplatin, capecitabine

Phase 2

Rectal Neoplasms

SAR292833

Phase 2

Neuropathic Pain

Vandetanib (ZD6474)

Phase 2

Advanced Breast Cancer

Liraglutide

Phase 2

Type 2 Diabetes Mellitus

fluoropyrimidine

Phase 2

Colorectal Cancer

Purified Vero Rabies Vaccine (VRVg) - Serum Free

Phase 2

Rabies

Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)

Phase 2

Esophageal Neoplasms

A/H5N1 Inactivated, split-virion pandemic influenza vaccine

Phase 2

Influenza

ICS/LABA therapy

Phase 2

Asthma

Dexamethasone

Phase 2

Hematological Malignancy

Laronidase

Phase 2

Mucopolysaccharidosis I

PRV-015

Phase 2

Celiac Disease

(ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis

Phase 2

Pertussis

Carboplatin

Phase 2

Carcinoma, Non-Small-Cell Lung

CYD Dengue Vaccine (5-dose formulation)

Phase 2

Dengue Fever

ChimeriVax-WN02 Low Dose

Phase 2

West Nile Fever

Enteric coated sevelamer

Phase 2

Hypercholesterolemia

Influenza virus vaccine 2009-2010 formulation

Phase 2

Influenza

Inactivated rabies virus vaccine

Phase 2

Dengue Virus

Pentavalent Meningococcal ABCYW vaccine

Phase 2

Meningococcal Immunization

Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus

Phase 2

Dengue

Rilzabrutinib dose 1

Phase 2

Graves' Disease

bsi-201 plus temozolomide

Phase 2

Glioblastoma

ILX651

Phase 2

Melanoma

recombinant human acid alpha-glucosidase (rhGAA)

Phase 2

Pompe Disease

Fitusiran (SAR439774)

Phase 2

Hemophilia A

RSV/hMPV vaccine candidate Dose L

Phase 2

Respiratory Syncytial Virus Infection

Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)

Phase 2

Influenza

Deferitrin (GT56-252)

Phase 2

Beta-Thalassemia

AVE2268

Phase 2

Type 2 Diabetes Mellitus

VRVg 2

Phase 2

Rabies Virus

Insulin glargine /lixisenatide Fixed Ratio Combination

Phase 2

Type 2 Diabetes Mellitus

Olipudase alfa

Phase 2

Niemann-Pick Disease

Polysaccharide Diphtheria Conjugate Vaccine

Phase 2

Meningitis

Smallpox vaccine, LISTER strain, from chick embryo cells

Phase 2

Smallpox

Tdap vaccine

Phase 2

Dermatitis Atopic

Blood draw for the laboratory assessment

Phase 2

Usher's Syndrome

oxaliplatin, 5 FU

Phase 2

Endometrial Cancer

Etoposide

Phase 2

Acute Lymphoblastic Leukemia

CYD Dengue Vaccine Serotypes 1, 2, 3, and 4

Phase 2

Dengue Virus

docetaxel and cisplatin

Phase 2

Ovarian Neoplasms

Genz-644470

Phase 2

Kidney Failure, Chronic

statins

Phase 2

Hypercholesterolaemia

Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA)

Phase 2

Influenza

Hexadecasaccharide (SR123781A)

Phase 2

Coronary Atherosclerosis

VASOPRESSIN V1B RECEPTOR ANTAGONIST (SSR149415)

Phase 2

Major Depressive Disorder

Bicalutamide

Phase 2

Prostate Cancer

Otamixaban (XRP0673)

Phase 2

Angioplasty, Transluminal, Percutaneous Coronary

SAR442168

Phase 2

Relapsing Multiple Sclerosis

Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV

Phase 2

Pertussis

AVE1625 B

Phase 2

Obesity

Bivalent CYD-1,3 Dengue (Vero) + Bivalent CYD-2,4 Dengue (Vero)

Phase 2

Dengue Virus

ZD6474 (vandetanib) 100mg

Phase 2

Non Small Cell Lung Carcinoma

alvocidib

Phase 2

Leukemia, Lymphocytic, Chronic

Zactima (vandetanib)

Phase 2

Prostate Cancer

Advate (Low Dose)

Phase 2

Hemophilia A

SSR180575

Phase 2

Diabetic Neuropathies

Itepekimab SAR440340

Phase 2

Chronic Obstructive Pulmonary Disease

ZD6474, Vandetanib

Phase 2

Non Small Cell Lung Cancer

SAR444836

Phase 2

Phenylketonuria

GZ402665

Phase 2

Sphingomyelin Lipidosis

Quadrivalent Influenza mRNA Vaccine MRT5413

Phase 2

Influenza Immunization

Isatuximab SC-OBDS

Phase 2

Plasma Cell Myeloma Refractory

SAR402663

Phase 2

Neovascular Age-related Macular Degeneration

Sargramostim (Leukine)

Phase 2

Crohn Disease

Menomune®: A, C, Y, W-135 Meningococcal Polysaccharide

Phase 2

Meningococcal Infections

Amisulpride

Phase 2

Bipolar Disorder

Haemophilus Influenzae Type b (Hib) vaccine

Phase 2

Meningitis

Yellow fever vaccine

Phase 2

Yellow Fever

G-CSF and plerixafor

Phase 2

Lymphoma, Non-Hodgkin

Yellow Fever

Phase 2

Dengue

SR31747A

Phase 2

Prostatic Neoplasm

Interferon-β

Phase 2

Multiple Sclerosis

BIVV020 (SAR445088)

Phase 2

Transplant Rejection

CoV2 preS dTM-AF03 (low-dose)

Phase 2

COVID-19 (Healthy Volunteers)

Menomune®: A, C, Y, W 135 Meningococcal Polysaccharide

Phase 2

Meningitis

SAR125844

Phase 2

Neoplasm Malignant

aminopterin

Phase 2

Leukemia

SAR445088 (IV)

Phase 2

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1

Phase 2

Influenza

anti-thymocyte globulin

Phase 2

Myelodysplastic Syndromes

Long term follow up in all patients who received SAR422459 in previous study TDU13583

Phase 2

Stargardt's Disease

sevelamer carbonate, sevelamer hydrochloride

Phase 2

Chronic Kidney Disease

Fluzone: Influenza virus vaccine

Phase 2

Influenza

Meningococcal Polysaccharide Diphtheria Protein Conjugate (Menactra®)

Phase 2

Meningitis

THOR-707

Phase 2

Oesophageal Squamous Cell Carcinoma

docetaxel and cisplatin followed by concurrent chemoradiotherapy with docetaxel and cisplatin + radiotherapy

Phase 2

Lung Neoplasms

Investigational hMPV/RSV vaccine

Phase 2

Human Metapneumovirus Immunization

Glucocorticoids

Phase 2

Immunoglobulin G4 Related Disease

SAR445399

Phase 2

Hidradenitis Suppurativa

Oxaliplatin, 5-Fluorouracil

Phase 2

Stomach Neoplasms

Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]

Phase 2

Renal Transplantation

SAR113945

Phase 2

Knee Osteoarthritis

XRP9881

Phase 2

Breast Cancer

Inactivated influenza vaccine (split virion)

Phase 2

Influenza

IRBESARTAN (SR47436)

Phase 2

Hypertension

Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1

Phase 2

Tetanus

Purified Vero Rabies Vaccine Serum Free (VRVg)

Phase 2

Rabies

tolterodine

Phase 2

Overactive Bladder

Plerixafor (AMD3100)

Phase 2

Lymphoma

Inactivated influenza vaccine (split virion) NH 2007-2008 formulation

Phase 2

Influenza

SAR440340

Phase 2

Asthma

Purified Vero Rabies Vaccine (VRVg)

Phase 2

Rabies

RSV vaccine candiate formulation 1

Phase 2

Respiratory Syncytial Virus Immunization

SAR110894

Phase 2

Dementia Alzheimer's Type

Oxaliplatin, capecitabine, radiotherapy

Phase 2

Rectal Neoplasms

Tetravalent CYD Dengue Vaccine , 5555 formulation

Phase 2

Dengue Fever

Meningococcal Polysaccharide (A, C, Y, and W 135) Tetanus Protein Conjugate Vaccine

Phase 2

Meningitis

SSR125543

Phase 2

Major Depression

Pandemic flu H5 mRNA vaccine

Phase 2

Influenza Immunization

ChimeriVax™-JE vaccine

Phase 2

Japanese Encephalitis

Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis

Phase 2

Dengue

Influenza virus (split virion, inactivated) vaccine

Phase 2

Influenza

MVA Smallpox vaccine

Phase 2

Smallpox

Nerispirdine

Phase 2

Multiple Sclerosis

2009-2010 Trivalent Influenza Virus Vaccine

Phase 2

Influenza

SAR442970

Phase 2

Crohn's Disease

Docetaxel + Oxaliplatin

Phase 2

Stomach Neoplasms

MenABCYW conjugate vaccine

Phase 2

Meningococcal Immunisation

S-1

Phase 2

Gastric Cancer

Clostridium difficile toxoids A and B (Low-dose with adjuvant)

Phase 2

Clostridium Difficile Infection

Any Inhaled Corticosteroids as prescribed by treating physician as standard of care

Phase 2

Chronic Obstructive Pulmonary Disease

Alglucosidase alfa (GZ419829)

Phase 2

Glycogen Storage Disease Type II-Pompe's Disease

PRN1008

Phase 2

Pemphigus Vulgaris

Nolpitantium besylate

Phase 2

Ulcerative Colitis

SSR149415

Phase 2

Depressive Disorder

CABAZITAXEL (XRP6258)

Phase 2

Prostatic Neoplasms

SAR445088 (BIVV020)

Phase 2

Immune Thrombocytopenia (ITP)

Quadrivalent Influenza mRNA Vaccine MRT5410

Phase 2

Influenza Immunization

Influenza virus vaccine (2004-2005 Formulation)

Phase 2

Influenza

Split virion, inactivated Influenza vaccine

Phase 2

Influenza

Topotecan

Phase 2

Small Cell Lung Cancer

gemcitabine plus carboplatin plus BSI-201

Phase 2

Triple Negative Breast Cancer

ARD6562, Docetaxel

Phase 2

Prostatic Neoplasms

Ad2/HIF-1α/VP16

Phase 2

Intermittent Claudication

SR147778

Phase 2

Obesity

Drug Name	Phase	Indication	Designations	Patent
JE-CV administered in Study JEC02	Phase 3	Encephalitis	-	-
Hepatitis A vaccine AVAXIM 80U	Phase 3	Hepatitis A	-	-
Poliomyelitis Vaccine inactivated	Phase 3	Poliomyelitis	-	-
Agalsidase beta	Phase 3	Fabry Disease	-	-
Interferon β-1a	Phase 3	Multiple Sclerosis	-	-
EMLA Cream	Phase 3	Facial Wrinkles at the Nasolabial Folds	-	-
Lactic Acid	Phase 3	Hygiene	-	-
Phosphatidylcholine	Phase 3	Hepatic and Hepatobiliary Disorders	-	-
somatropin	Phase 3	Fetal Growth Retardation	-	-
Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative	Phase 3	Influenza	-	-
Nirsevimab	Phase 3	RSV Immunization	-	-
Inhaled Corticosteroid	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Saredutant succinate (SR48968C)	Phase 3	Depressive Disorder	-	-
Eliglustat, GZ385660	Phase 3	Gaucher Disease	-	-
insulin glulisine / insulin glargine	Phase 3	Diabetes Mellitus, Type 1	-	-
Lactic Acid (Dermacyd PH_DETINLYN Tangerine Mix)	Phase 3	Hygiene	-	-
Flu-ID 15μg	Phase 3	Influenza	-	-
Insulin Therapy	Phase 3	Diabetes Mellitus, Type 2	-	-
factor concentrates	Phase 3	Hemophilia A	-	-
Vaxneuvance vaccine	Phase 3	Pneumococcal Immunization	-	-
lactoserum	Phase 3	Hygiene	-	-
Bypassing agents	Phase 3	Hemophilia A	-	-
Docetaxel	Phase 3	Stomach Neoplasms	-	-
Irbesartan	Phase 3	Hypertension	-	-
Dupilumab SAR231893	Phase 3	Chronic Spontaneous Urticaria	-	-
DTaP-IPV-HB-PRP~T	Phase 3	Diphtheria	-	-
DT5aP-IPV-Hib 5-component Pertussis vaccine	Phase 3	Infant	-	-
MRI contrast-enhancing agents	Phase 3	Multiple Sclerosis	-	-
Open-label Semuloparin sodium	Phase 3	Venous Thromboembolism	-	-
Inactivated Split-virion influenza vaccine	Phase 3	Orthomyxoviridae Infection	-	-
AVANAFIL	Phase 3	Sexual Function and Fertility Disorders NEC-Erectile Dysfunction	-	-
Adalimumab	Phase 3	Rheumatoid Arthritis	-	-
Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains (QIV-SD)	Phase 3	Influenza Immunization	-	-
Purified inactivated rabies vaccine, serum free	Phase 3	Rabies	-	-
clofarabine (IV formulation)	Phase 3	Acute Myelogenous Leukemia	-	-
Irbesartan/hydrochlorothiazide	Phase 3	Hypertension	-	-
sevelamer carbonate (Renvela®) sevelamer hydrochloride (Renagel ®)	Phase 3	Chronic Kidney Disease	-	-
HOE901-U300 (Insulin glargine new formulation)	Phase 3	Type 1 Diabetes Mellitus	-	-
Euvax B®: Hepatitis B vaccine	Phase 3	Hepatitis B	-	-
XRP6976	Phase 3	Stomach Neoplasm	-	-
Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virus	Phase 3	Dengue Fever	-	-
enoxaparin (XRP4563)	Phase 3	Hip Fractures	-	-
Otamixaban	Phase 3	Acute Coronary Syndrome	-	-
DTaP-HB-PRP~T vaccine + OPV	Phase 3	Diphtheria	-	-
paclitaxel	Phase 3	Uterine Carcinosarcoma	-	-
Prednisone or Prednisolone	Phase 3	Prostatic Neoplasms	-	-
Sevelamer carbonate (Renvela®)	Phase 3	Kidney Diseases	-	-
Leucovorin	Phase 3	Pancreatic Neoplasms	-	-
Pomalidomide	Phase 3	Plasma Cell Myeloma	-	-
Meningococcal polysaccharide group A, C, W-135 and Y Conjugate vaccine	Phase 3	Meningococcal Immunisation (Healthy Volunteers)	-	-
Sevelamer Hydrochloride (Renagel®)	Phase 3	Peritoneal Dialysis	-	-
Antihyperglycemic Drug	Phase 3	Hypercholesterolaemia	-	-
Metformin	Phase 3	Type 2 Diabetes Mellitus	-	-
insulin glulisine	Phase 3	Diabetes Mellitus	-	-
Thiocolchicoside+Ketoprofen	Phase 3	Low Back Pain	-	-
Yellow fever vaccine (live)	Phase 3	Yellow Fever Immunization	-	-
Riluzole	Phase 3	Huntington Disease	-	-
SENNA+CASSIA	Phase 3	Constipation	-	-
clopidogrel (SR25990C)	Phase 3	Atrial Fibrillation	-	-
High-Dose Quadrivalent Influenza Vaccine, (Zonal Purified, Split Virus) 2020-2021 Strains (QIV-HD)	Phase 3	Influenza Immunization	-	-
Fitusiran	Phase 3	Hemophilia	-	-
DTaP-HB-PRP~T vaccine	Phase 3	Diphtheria	-	-
CABAZITAXEL	Phase 3	Prostate Cancer Metastatic	-	-
DTaP-IPV-Hep B-PRP~T combined vaccine	Phase 3	Diphtheria	-	-
Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined	Phase 3	Meningitis	-	-
Duvakitug	Phase 3	Ulcerative Colitis	-	-
Warfarin	Phase 3	Embolism	-	-
Oral corticosteroid therapy (prednisone/prednisolone)	Phase 3	Asthma	-	-
ambroxol BIH1526	Phase 3	Pharyngitis	-	-
SR34006	Phase 3	Pulmonary Embolism	-	-
Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)	Phase 3	Japanese Encephalitis	-	-
carfilzomib	Phase 3	Plasma Cell Myeloma	-	-
Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine	Phase 3	Meningococcal Meningitis	-	-
Non-insulin antihyperglycemic drugs	Phase 3	Type 2 Diabetes Mellitus	-	-
Eliglustat tartrate	Phase 3	Gaucher Disease, Type 1	-	-
irinotecan hydrochloride	Phase 3	Colorectal Cancer	-	-
INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)	Phase 3	Type 2 Diabetes Mellitus	-	-
tolevamer potassium-sodium (GT267-004)	Phase 3	Clostridium Enterocolitis	-	-
Teplizumab	Phase 3	Type 1 Diabetes Mellitus	-	-
Inactive Poliovirus Vaccine	Phase 3	Poliomyelitis	-	-
Riliprubart Prefilled Pen (PFP)	Phase 3	Polyneuropathy, Inflammatory Demyelinating, Chronic	-	-
FEX60/PE10	Phase 3	Rhinitis Allergic	-	-
Insulin monotherapy with premixed insulin NPH 30/70	Phase 3	Diabetes Mellitus, Type 2	-	-
Topical calcineurin inhibitors	Phase 3	Dermatitis Atopic	-	-
Meningococcal polysaccharide (serogroups A,C,Y and W-135) diphtheria toxoid conjugate vaccine	Phase 3	Meningococcal Immunization	-	-
HBVAXPRO 5µg	Phase 3	Virus Diseases	-	-
escitalopram	Phase 3	Depressive Disorder	-	-
Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV)	Phase 3	Meningococcal Immunisation	-	-
SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent D614) (primary series)	Phase 3	COVID-19	-	-
Moisturizers	Phase 3	Neurodermatitis	-	-
sutimlimab (BIVV009)	Phase 3	Cold Agglutinin Disease	-	-
Antidiabetic background therapy	Phase 3	Type 2 Diabetes	-	-
Glucocorticoid	Phase 3	Immunoglobulin G4 Related Disease	-	-
PCV21 vaccine	Phase 3	Pneumococcal Immunization	-	-
Inactivated, split-virion influenza vaccine	Phase 3	Orthomyxoviridae Infection	-	-
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate vaccine)	Phase 3	Meningococcal Immunisation	-	-
Imiglucerase	Phase 3	Gaucher Disease, Type 1	-	-
Zolpidem (SL800750)	Phase 3	Attention Deficit Hyperactivity Disorder	-	-
Vandetanib (SAR390530)	Phase 3	Differentiated Thyroid Cancer	-	-
Itepekimab (SAR440340)	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Riliprubart	Phase 3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy	-	-
teriflunomide (HMR1726)	Phase 3	Multiple Sclerosis	-	-
Sarilumab	Phase 3	RA	-	-
Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative	Phase 3	Influenza	-	-
paroxetine	Phase 3	Depressive Disorder, Major	-	-
Semuloparin Sodium	Phase 3	Venous Thromboembolism	-	-
Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib	Phase 3	Diphtheria	-	-
Meningococcal polysaccharide diphtheria toxoid conjugate	Phase 3	Meningitis	-	-
GEMIGLIPTIN LS15-0444	Phase 3	Type 2 Diabetes Mellitus	-	-
FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)	Phase 3	Colorectal Neoplasms	-	-
afuzosin	Phase 3	Benign Prostatic Hyperplasia	-	-
Fexofenadine M016455	Phase 3	Rhinitis Seasonal	-	-
Idrabiotaparinux sodium	Phase 3	Deep Venous Thrombosis	-	-
rFVIIIFc	Phase 3	Hemophilia A	-	-
LACTIC ACID(ND)	Phase 3	Hygiene	-	-
Antithrombin concentrate (ATIIIC)	Phase 3	Hemophilia	-	-
Allopurinol	Phase 3	Tumor Lysis Syndrome	-	-
BPA prophylaxis	Phase 3	Hemophilia	-	-
Insulin human/Insuman Comb 25 (HR1799)	Phase 3	Type 2 Diabetes Mellitus	-	-
RSVt vaccine	Phase 3	RSV Immunization	-	-
SR123781A	Phase 3	Venous Thromboembolism	-	-
Doxorubicine + docetaxel sequential	Phase 3	Breast Neoplasms	-	-
Influenza Virus Vaccine USP Trivalent Types A and B	Phase 3	Orthomyxoviridae Infection	-	-
DTaP-IPV-Hep B- PRP~T + Prevenar + Rotarix vaccine	Phase 3	Diphtheria	-	-
Sulfonylurea	Phase 3	Type 2 Diabetes Mellitus	-	-
Quadrivalent Influenza Vaccine (split virion, inactivated)	Phase 3	Influenza	-	-
Oxaliplatin + 5-Fluorouracil/Leucovorin	Phase 3	Carcinoma, Hepatocellular	-	-
Investigational Quadrivalent Inactivated Influenza Vaccine, No Preservative	Phase 3	Influenza	-	-
DTaP-IPV combined vaccine	Phase 3	Pertussis	-	-
SENNA+CASSIA(Naturetti)	Phase 3	Constipation	-	-
FluCAM [Fludara + Campath]	Phase 3	B-Cell Chronic Lymphocytic Leukemia	-	-
paracetamol 4.8% paediatric oral suspension	Phase 3	Fever	-	-
DTaP-HB PRP~T Combined Vaccine	Phase 3	Diphtheria	-	-
Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)	Phase 3	Hygiene	-	-
NPH human insulin	Phase 3	Diabetes Mellitus, Type 2	-	-
Insulin glargine U300 (new formulation of insulin glargine) HOE901	Phase 3	Diabetes Mellitus Type 2	-	-
FluBlok®	Phase 3	Influenza	-	-
Insulin glargine (HOE901)	Phase 3	Type 2 Diabetes Mellitus	-	-
Measles, combinations with mumps and rubella, live attenuated	Phase 3	Yellow Fever Immunization	-	-
Pneumo 23	Phase 3	Streptococcus Pneumoniae	-	-
CELIVARONE (SSR149744C)	Phase 3	Atrial Fibrillation	-	-
amiodarone	Phase 3	Atrial Fibrillation	-	-
Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus	Phase 3	Dengue Fever	-	-
Atorvastatin	Phase 3	Hypercholesterolemia	-	-
Thyrogen (thyrotropin alfa for injection)	Phase 3	Differentiated Thyroid Cancer	-	-
Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid)	Phase 3	Hygiene	-	-
Exenatide	Phase 3	Diabetes Mellitus, Type 2	-	-
Glutamine	Phase 3	Colorectal Neoplasms	-	-
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL)	Phase 3	Diphtheria	-	-
Cholestyramine	Phase 3	Multiple Sclerosis	-	-
Prevnar 20 vaccine	Phase 3	Pneumococcal Immunization	-	-
Doxorubicin	Phase 3	Breast Neoplasms	-	-
rFIXFc	Phase 3	Hemophilia B	-	-
Humalog	Phase 3	Type 1 Diabetes Mellitus	-	-
Docetaxel, Cisplatin, 5-fluorouracil (5-FU), radiotherapy	Phase 3	Head and Neck Neoplasms	-	-
Live, attenuated, dengue serotype 1, 2, 3, 4 virus	Phase 3	Dengue	-	-
Sitagliptin	Phase 3	Diabetes Mellitus, Type 2	-	-
Teriflunomide HMR1726	Phase 3	Relapsing Multiple Sclerosis	-	-
Cyclophosphamide	Phase 3	Breast Neoplasms	-	-
Alirocumab SAR236553	Phase 3	Hypercholesterolaemia	-	-
CYD Dengue vaccine	Phase 3	Dengue Fever	-	-
Teriflunomide	Phase 3	Multiple Sclerosis	-	-
Meningococcal polysaccharide groups A, C, W-135 and Y Conjugate vaccine	Phase 3	Meningitis	-	-
JE-VAX®	Phase 3	Japanese Encephalitis	-	-
Avalglucosidase alfa (GZ402666)	Phase 3	Glycogen Storage Disease Type II;Pompe's Disease	-	-
aflibercept	Phase 3	Colorectal Neoplasms	-	-
Corticosteroids	Phase 3	Thrombotic Thrombocytopenic Purpura	-	-
Concomitant administration	Phase 3	Diphtheria	-	-
Diphteria, tetanus, and Acellular Pertussis vaccine	Phase 3	Diphtheria	-	-
Isatuximab SAR650984	Phase 3	Multiple Myeloma	-	-
M-M-R II vaccine	Phase 3	Pneumococcal Immunization	-	-
docetaxel, doxorubicin, cyclophosphamide	Phase 3	Breast Cancer	-	-
JE-CV Vaccine	Phase 3	Japanese Encephalitis	-	-
Bortezomib	Phase 3	Plasma Cell Myeloma	-	-
Insulin glargine,300 U/mL	Phase 3	Type 1 Diabetes Mellitus	-	-
Meningococcal Group C Conjugate vaccine: MenC	Phase 3	Meningitis	-	-
S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + 5-chloro-2, 4-dihydroxypyridine (CDHP) (Gimeracil) + Oxo (Oteracil)	Phase 3	Gastric Cancer	-	-
Influenza Virus Vaccine	Phase 3	Influenza	-	-
Purified vero rabies vaccine - serum free VRVg-2	Phase 3	Rabies (Healthy Volunteers)	-	-
Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell	Phase 3	Cholera	-	-
QIV-HD	Phase 3	Influenza	-	-
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine	Phase 3	Meningitis	-	-
DTaP-IPV-HB-PRP~T vaccine	Phase 3	Diphtheria	-	-
Spores of Bacillus Clausii Probiotic Strain	Phase 3	Diarrhea	-	-
REPEVAX	Phase 3	Healthy	-	-
Alirocumab	Phase 3	Hypercholesterolemia	-	-
PEDIACEL® and Prevenar®	Phase 3	Diphtheria	-	-
Oral anti-diabetic drugs	Phase 3	Type 2 Diabetes Mellitus	-	-
Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed	Phase 3	Tetanus	-	-
Oxaliplatin	Phase 3	Carcinoma, Hepatocellular	-	-
ZD6474 (vandetanib)	Phase 3	Thyroid Cancer	-	-
Live, attenuated dengue serotype 1, 2, 3, and 4 virus	Phase 3	Dengue	-	-
SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1	Phase 3	COVID-19	-	-
omega-3 polyunsaturated fatty acids (PUFA)	Phase 3	Diabetes Mellitus, Non-Insulin-Dependent	-	-
acetylsalicyclic acid (ASA)	Phase 3	Acute Coronary Disease	-	-
Hexaxim®	Phase 3	Diphtheria	-	-
High-Dose Quadrivalent Influenza Vaccine	Phase 3	Influenza (Healthy Volunteers)	-	-
Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine	Phase 3	Meningitis	-	-
gemcitabine/Eloxatin (GEMOX)	Phase 3	Carcinoma, Non-Small-Cell Lung	-	-
Non sedating H1-antihistamine	Phase 3	Cold Urticaria	-	-
Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus	Phase 3	Tetanus	-	-
Meningococcal Diphtheria Toxoid Vaccine	Phase 3	Meningitis	-	-
Insulin glargine (U300)	Phase 3	Type 2 Diabetes Mellitus	-	-
Alfuzosin	Phase 3	Acute Urinary Retention	-	-
Tocilizumab	Phase 3	Rheumatoid Arthritis	-	-
Budesonide	Phase 3	Chronic Rhinosinusitis With Nasal Polyps	-	-
enoxaparin	Phase 3	Abdominal Neoplasms	-	-
HDCV	Phase 3	Healthy Volunteers (Rabies Immunization)	-	-
High-Dose trivalent influenza vaccine (Split virion, Inactivated)	Phase 3	Influenza	-	-
Docetaxel/DDP	Phase 3	Lung Neoplasms	-	-
SAR153191 (REGN88)	Phase 3	Rheumatoid Arthritis	-	-
PVRV	Phase 3	Rabies	-	-
Insulin aspart	Phase 3	Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus	-	-
DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus)	Phase 3	Pertussis Immunisation	-	-
Japanese encephalitis vaccine	Phase 3	Japanese Encephalitis	-	-
Caplacizumab (ALX-0081)	Phase 3	Thrombotic Thrombocytopenic Purpura	-	-
ChimeriVax™-JE	Phase 3	Japanese Encephalitis	-	-
Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant.	Phase 3	Dengue Fever	-	-
Inhaled Long-Acting Beta Agonist	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Saredutant (SR48968C)	Phase 3	Depressive Disorder	-	-
Fluorouracil	Phase 3	Colorectal Cancer Metastatic	-	-
Quadrivalent Recombinant influenza vaccine (RIV4) season/2022-2023/NH	Phase 3	Influenza Immunization	-	-
IVIg	Phase 3	Chronic Inflammatory Demyelinating Polyneuropathy	-	-
Alemtuzumab 12 mg	Phase 3	Multiple Sclerosis, Relapsing-Remitting	-	-
saredutant (SR48968)	Phase 3	Major Depressive Disorder	-	-
Bacillus Clausii	Phase 3	Gastroenteritis	-	-
Capecitabine	Phase 3	Stomach Neoplasms	-	-
Amlitelimab	Phase 3	Dermatitis Atopic	-	-
DTaP//PRP-T Combined Vaccine	Phase 3	Diphtheria	-	-
Hexavalent vaccine	Phase 3	Neisseria Meningitidis	-	-
Prednisone	Phase 3	Chronic Graft Versus Host Disease	-	-
Rosuvastatin	Phase 3	Hypercholesterolemia	-	-
Dermacyd Breeze Pocket BR (Lactic Acid)	Phase 3	Hygiene	-	-
IMOJEV	Phase 3	Japanese Encephalitis	-	-
sodium hyaluronate	Phase 3	Osteoarthritis of Shoulder	-	-
High-Dose Inactivated, Split-Virion Influenza Vaccine	Phase 3	Orthomyxoviridae Infection	-	-
zolpidem-MR (modified release)	Phase 3	Sleep Initiation and Maintenance Disorders	-	-
Tritanrix-HepB/Hib	Phase 3	Diphtheria	-	-
riferminogene pecaplasmid	Phase 3	Peripheral Vascular Diseases	-	-
Live attenuated Japanese encephalitis chimeric virus vaccine	Phase 3	Japanese Encephalitis	-	-
Quadrivalent Influenza Vaccine	Phase 3	Influenza	-	-
Iniparib (SAR240550/BSI-201)	Phase 3	Solid Tumors	-	-
dianicline	Phase 3	Smoking	-	-
Insulin glargine (HOE901) (Lantus)	Phase 3	Type 1 Diabetes Mellitus	-	-
FDC KETOPROFEN+OMEPRAZOLE	Phase 3	Pain	-	-
Clotting factor concentrates (CFC) or bypassing agents (BPA)	Phase 3	Hemophilia	-	-
Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®	Phase 3	Diphtheria	-	-
Aldurazyme	Phase 3	Mucopolysaccharidosis I	-	-
DAPTACEL®. (DTaP), IPOL®., and ActHIB®.	Phase 3	Diphtheria	-	-
Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine	Phase 3	Neisseria Meningitidis	-	-
Levofloxacin	Phase 3	Prostatitis	-	-
Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis)	Phase 3	Tetanus	-	-
xaliproden (SR57746A)	Phase 3	Alzheimer Disease	-	-
Triamcinolone	Phase 3	Rhinitis, Allergic, Perennial	-	-
Glycerine Vegetal Soap Granado Traditional	Phase 3	Hygiene	-	-
sevelamer carbonate 800mg	Phase 3	Renal Failure Chronic	-	-
Asthma Controller Therapies	Phase 3	Asthma	-	-
Ciclesonide (XRP1526)	Phase 3	Asthma	-	-
Interferon beta-1a	Phase 3	Multiple Sclerosis, Relapsing-Remitting	-	-
larotaxel (RPR109881, XRP9881)	Phase 3	Breast Cancer	-	-
larotaxel (XRP9881)	Phase 3	Advanced Breast Cancer	-	-
Venglustat (GZ402671)	Phase 3	Fabry Disease	-	-
Asthma Controller Therapies (include prednisone/prednisolone)	Phase 3	Asthma	-	-
triamcinolone XRG5029	Phase 3	Rhinitis Allergic	-	-
lormetazepam	Phase 3	Sleep Initiation and Maintenance Disorders	-	-
MAXOMAT ®, biosynthetic growth hormone	Phase 3	Noonan Syndrome	-	-
5-fluorouracil	Phase 3	Breast Cancer	-	-
Quadrivalent Recombinant Influenza Vaccine (RIV4)	Phase 3	Influenza (Healthy Volunteers)	-	-
Non-statin LMT	Phase 3	Hypercholesterolemia	-	-
SGLT2 inhibitor	Phase 3	Type 2 Diabetes Mellitus	-	-
DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)	Phase 3	Diphtheria	-	-
Erlotinib	Phase 3	Non Small Cell Lung Cancer	-	-
Quadrivalent influenza vaccine (QIV) (split virion, inactivated) Northern Hemisphere (NH) 2015-2016	Phase 3	Influenza	-	-
insulin secretagogue	Phase 3	Diabetes Mellitus, Type 2	-	-
alemtuzumab	Phase 3	B Cell Chronic Lymphocytic Leukemia	-	-
hydroxychloroquine (Z0188)	Phase 3	Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus	-	-
DTaP-IPV//PRP~T combined vaccine	Phase 3	Diphtheria	-	-
Sulfasalazine	Phase 3	Rheumatoid Arthritis	-	-
Infanrix® -IPV+Hib	Phase 3	Pertussis	-	-
Caplacizumab	Phase 3	Acquired Thrombotic Thrombocytopenic Purpura	-	-
Telithromycin (HMR3647)	Phase 3	Pneumonia	-	-
Ombrabulin (AVE8062)	Phase 3	Ovarian Cancer Recurrent	-	-
Topical corticosteroids	Phase 3	Dermatitis Atopic	-	-
lunsekimig	Phase 3	Chronic Rhinosinusitis With Nasal Polyps	-	-
Insulin Aspart SAR341402	Phase 3	Type 1 Diabetes Mellitus	-	-
Granulocyte-colony stimulating factor (G-CSF)	Phase 3	Non-Hodgkin's Lymphoma	-	-
Plerixafor	Phase 3	Multiple Myeloma	-	-
volinanserin (M100907)	Phase 3	Sleep Initiation and Maintenance Disorders	-	-
Azithromycin	Phase 3	Lung Transplant Rejection	-	-
HBVaxPRO® 5 µg / 0.5 mL	Phase 3	Hepatitis B	-	-
Pemetrexed	Phase 3	Non Small Cell Lung Cancer	-	-
BIVV009	Phase 3	Agglutinin Disease, Cold	-	-
irbesartan/amlodipine	Phase 3	Hypertension	-	-
Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine	Phase 3	Meningococcal Immunisation (Healthy Volunteers)	-	-
eplivanserin (SR46349)	Phase 3	Sleep Initiation and Maintenance Disorders	-	-
Lipid Modifying Therapy (LMT)	Phase 3	Hypercholesterolemia	-	-
SR121463B	Phase 3	Inappropriate ADH Syndrome	-	-
Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus	Phase 3	Dengue	-	-
Clopidogrel	Phase 3	Thrombosis	-	-
PCV21	Phase 3	Pneumococcal Infections	-	-
epidoxorubicine, ciclophosphamide, methotrexate, fluorouracile	Phase 3	Breast Neoplasms	-	-
Low Dose (LD) RSVt vaccine	Phase 3	RSV Immunisation	-	-
Lactic acid (Dermacid)	Phase 3	Healthy	-	-
Dermacyd PH_DETINLYN (Lactic Acid)	Phase 3	Hygiene	-	-
Influenza virus vaccine (split virion, inactivated)	Phase 3	Influenza	-	-
MenACYW conjugate vaccine	Phase 3	Meningococcal Infections	-	-
Rilzabrutinib	Phase 3	Immune Thrombocytopenia	-	-
Typhoid Vi polysaccharide	Phase 3	Salmonella Infections	-	-
ketoprofen 100 mg	Phase 3	Pain	-	-
risedronate (HMR4003)	Phase 3	Osteoporosis, Postmenopausal	-	-
Enoxaparin sodium	Phase 3	Venous Thromboembolism	-	-
Diphtheria, tetanus, polio and pertussis vaccination	Phase 3	Diphtheria	-	-
REVAXIS®	Phase 3	Diphtheria	-	-
Mometasone furoate nasal spray (MFNS)	Phase 3	Chronic Rhinosinusitis With Nasal Polyps	-	-
Purified vero rabies vaccine - serum free - VRVg-2	Phase 3	Rabies	-	-
Lantus (Insulin glargine)	Phase 3	Type 2 Diabetes Mellitus	-	-
Dupilumab SAR231893 (REGN668)	Phase 3	Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)	-	-
Insulin glargine	Phase 3	Diabetes Mellitus, Type 1	-	-
Ezetimibe	Phase 3	Hypercholesterolemia	-	-
fexofenadine/Allegra (M016455)	Phase 3	Atopic Dermatitis	-	-
NPH insulin	Phase 3	Type 1 Diabetes Mellitus	-	-
Insulin glargine/lixisenatide fixed ratio combination	Phase 3	Type 2 Diabetes Mellitus	-	-
Cetylpyridinium chloride	Phase 3	Hygiene	-	-
DTaP-IPV-Hep B-PRP~T combined vaccine + Pneumococcal polysaccharide	Phase 3	Diphtheria	-	-
zolpidem-MR (SL800750)	Phase 3	Sleep Initiation and Maintenance Disorders	-	-
Dupilumab	Phase 3	Lichen Simplex Chronicus	-	-
Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine	Phase 3	Diphtheria	-	-
ChimeriVax-JE, Japanese Encephalitis vaccine	Phase 3	Encephalitis	-	-
REPEVAX® after REVAXIS®	Phase 3	Healthy Adult	-	-
CombAct-HIB®	Phase 3	Hepatitis B	-	-
Alfuzosin (SL770499)	Phase 3	Urinary Retention	-	-
Pioglitazone	Phase 3	Diabetes Mellitus Type 2	-	-
volinanserin	Phase 3	Sleep Initiation and Maintenance Disorders	-	-
DOCETAXEL(XRP6976) + MODAFINIL	Phase 3	Prostatic Neoplasms	-	-
clopidogrel (SR25990)	Phase 3	Stable Angina	-	-
vinorelbine tartrate	Phase 3	Lung Cancer	-	-
Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant	Phase 3	Dengue Fever	-	-
Irinotecan	Phase 3	Carcinoma, Non-Small-Cell Lung	-	-
avalglucosidase alfa	Phase 3	Glycogen Storage Disease Type II	-	-
Lantus (insulin glargine [rDNA origin] injection)	Phase 3	Diabetes Mellitus	-	-
Lactic acid (Dermacyd Femina)	Phase 3	Hygiene	-	-
Frexalimab	Phase 3	Type 1 Diabetes Mellitus	-	-
XRP6976 (Docetaxel/Taxotere)	Phase 3	Cancer	-	-
Glimepiride and Metformin hydrochloride combination (HOE490)	Phase 3	Type 2 Diabetes Mellitus	-	-
Low to medium potent topical corticosteroids	Phase 3	Neurodermatitis	-	-
Diphteria/Tetanus/Polio/Acellular Pertussis/Hib vaccine	Phase 3	Diphtheria	-	-
Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower	Phase 3	Hygiene	-	-
Fexofenadine	Phase 3	Seasonal Allergic Rhinitis	-	-
SR58611A	Phase 3	Anxiety Disorders	-	-
Lixisenatide (AVE0010)	Phase 3	Diabetes Mellitus, Type 2	-	-
Tirapazamine	Phase 3	Head and Neck Squamous Cell Carcinoma	-	-
Isatuximab IV	Phase 3	Plasma Cell Myeloma Recurrent	-	-
Generic = Plerixafor	Phase 3	Lymphoma (Non-Hodgkin's Lymphoma)	-	-
amlodipine	Phase 3	Hypertension	-	-
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®)	Phase 3	Meningitis	-	-
DAPTACEL®: DTaP	Phase 3	Diphtheria	-	-
Dermacyd PH_DETINBACK (Lactic Acid)	Phase 3	Hygiene	-	-
Granulocyte colony-stimulating factor plus plerixafor	Phase 3	Lymphoma, Non-Hodgkin	-	-
Piperacillin/Tazobactam	Phase 3	Pneumonia	-	-
MenACYW-135 conjugate vaccine	Phase 3	Healthy Volunteers (Meningococcal Infection)	-	-
Multi-dose Quadrivalent Influenza Vaccine	Phase 3	Influenza	-	-
Saredutant	Phase 3	Generalized Anxiety	-	-
Irbesartan/Amlodipine (150/5mg)	Phase 3	Hypertension	-	-
Docetaxel (XRP6976)	Phase 3	Prostate Cancer	-	-
Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)	Phase 3	Healthy Volunteers (Meningococcal Infection)	-	-
Methotrexate	Phase 3	Uveitis	-	-
Folic acid	Phase 3	Rheumatoid Arthritis	-	-
Mometasone furoate nasal spray	Phase 3	Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)	-	-
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate	Phase 3	Meningitis	-	-
Tolebrutinib	Phase 3	Primary Progressive Multiple Sclerosis	-	-
Glimepiride+metformin (Amaryl M®) - HOE4900	Phase 3	Type 2 Diabetes Mellitus	-	-
Leflunomide	Phase 3	Systemic Lupus Eythematosus (SLE)	-	-
Inactivated Poliomyelitis vaccine	Phase 3	Poliomyelitis	-	-
SR57746A	Phase 3	Metastases	-	-
glimepiride	Phase 3	Type 2 Diabetes Mellitus	-	-
DTaP-IPV-Hep B-PRP-T Vaccine	Phase 3	Diphtheria	-	-
rimonabant	Phase 3	Smoking Cessation	-	-
VRVg-2	Phase 3	Rabies (Healthy Volunteers)	-	-
HOE901-U300 (new formulation of insulin glargine)	Phase 3	Type 2 Diabetes Mellitus	-	-
Basal Insulin	Phase 3	Diabetes Mellitus, Type 2	-	-
AVE7688	Phase 3	Hypertension	-	-
cisplatin	Phase 3	Nasopharyngeal Neoplasms	-	-
DTaP-IPV/Hib Combined vaccine	Phase 3	Tetanus	-	-
Purified vero rabies vaccine - serum free	Phase 3	Rabies (Healthy Volunteers)	-	-
Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus	Phase 3	Japanese Encephalitis	-	-
DTaP-IPV-HB-PRP~T and Pneumococcal polysaccharide vaccines	Phase 3	Hepatitis B	-	-
Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine	Phase 3	Healthy Volunteers (Meningococcal Infection)	-	-
AFLIBERCEPT AVE0005	Phase 3	Colorectal Cancer Metastatic	-	-
TdcP-IPV vaccine	Phase 3	Diphtheria	-	-
pristinamycin	Phase 3	Tonsillitis	-	-
KETOPROFEN(RP19583)	Phase 3	Pain	-	-
5-fluorouracil (5-FU)	Phase 3	Head and Neck Neoplasms	-	-
Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine	Phase 3	Meningococcal Infection	-	-
DTaP IPV HB PRP~T vaccine	Phase 3	Diphtheria	-	-
Neutral Protamine Hagedorn (NPH) insulin	Phase 3	Type 1 Diabetes Mellitus	-	-
Telithromycin	Phase 3	Maxillary Sinusitis	-	-
Dronedarone (SR33589)	Phase 3	Atrial Fibrillation	-	-
fexofenadine HCL (M016455)	Phase 3	Rhinitis Seasonal	-	-
Simvastatin	Phase 3	Hypercholesterolemia	-	-
Eplivanserin	Phase 3	Sleep Initiation and Maintenance Disorders	-	-
SanOrg34006	Phase 3	Deep Vein Thrombosis	-	-
20vPCV licensed vaccine	Phase 3	Pneumococcal Immunization	-	-
Measles-mumps-rubella-varicella vaccine	Phase 3	Meningococcal Meningitis	-	-
PENTAXIM™: DTacP IPV//PRP~T combined vaccine	Phase 3	Diphtheria	-	-
Sevelamer Carbonate (GZ419831)	Phase 3	Hyperphosphatemia	-	-
amibegron (SR58611A)	Phase 3	Major Depressive Disorders	-	-
hydroxychloroquine	Phase 3	Rheumatoid Arthritis	-	-
rimonabant (SR141716)	Phase 3	Obesity	-	-
Meningococcal Polysaccharide Diphtheria Conjugate Vaccine	Phase 3	Meningococcal Meningitis	-	-
SODIUM DIVALPROATE	Phase 3	Bipolar Disorder	-	-
Vandetanib	Phase 3	Non-small Cell Lung Cancer	-	-
SR34006 (idraparinux sodium) Injection	Phase 3	Pulmonary Embolism	-	-
Dermacid Silver (Lactic acid)	Phase 3	Hygiene	-	-
MenACYW135 polysaccharide vaccine	Phase 3	Meningococcal Infection	-	-
Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate	Phase 3	Meningitis	-	-
Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation	Phase 3	Influenza	-	-
Fexofenadine (loratadine if not available)	Phase 3	Pruritus	-	-
gemcitabine/carboplatin	Phase 3	Squamous Cell Lung Cancer	-	-
gemcitabine	Phase 3	Non-small Cell Lung Cancer Stage IV	-	-
Satavaptan	Phase 3	Ascites	-	-
Sevelamer carbonate	Phase 3	Chronic Kidney Disease	-	-
SAR342434	Phase 3	Type 2 Diabetes Mellitus	-	-
alglucosidase alfa	Phase 3	Pompe Disease (Late-onset)	-	-
HUMAN INSULIN (BIOSYNTHETIC)	Phase 3	Diabetes Mellitus, Type 1	-	-
somatropine	Phase 3	Growth Hormone Deficiency	-	-
ticlopidine	Phase 3	Peripheral Arterial Disease (PAD)	-	-
Sarilumab SAR153191 (REGN88)	Phase 3	Juvenile Idiopathic Arthritis	-	-
Oxaliplatin (SR96669)	Phase 3	Colonic Neoplasms	-	-
ARTESUNATE + AMODIAQUINE	Phase 3	Malaria	-	-
Japanese encephalitis chimeric virus vaccine (JE-CV)	Phase 3	Encephalitis	-	-
risedronate	Phase 3	Osteoporosis	-	-
MMR	Phase 3	Meningitis, Meningococcal	-	-
Inhaled corticosteroid (ICS) therapy	Phase 3	Asthma	-	-
Adacel® (Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis)	Phase 3	Diphtheria	-	-
ciclesonide	Phase 3	Asthma	-	-
DTaP-HB-PRP~T combined vaccine	Phase 3	Diphtheria	-	-
Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)	Phase 3	Pulmonary Diseases	-	-
Insuline Glulisine	Phase 3	Diabetes Mellitus, Type 1	-	-
DTaP-IPV-Hep B-PRP~T vaccine (Batch 1)	Phase 3	Diphtheria	-	-
Trivalent Influenza Vaccine 1 SP Shz TIV1	Phase 3	Influenza	-	-
Alirocumab SAR236553 (REGN727)	Phase 3	Hypercholesterolaemia	-	-
2011 to 2012 Trivalent Influenza Vaccine	Phase 3	Influenza	-	-
Lipid-Modifying Therapy (LMT)	Phase 3	Hypercholesterolemia	-	-
A/H1N1 pandemic influenza vaccine (non- adjuvanted)	Phase 3	Influenza	-	-
Glimepiride (HOE490)	Phase 3	Type 2 Diabetes Mellitus	-	-
75% insulin lispro protamine suspension and 25 % insulin lispro injection	Phase 3	Diabetes Mellitus, Type 2	-	-
DTaP-IPV//PRP~T combined	Phase 3	Hepatitis B	-	-
Insulin glargine/Lixisenatide	Phase 3	Type 2 Diabetes Mellitus	-	-
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®	Phase 3	Meningitis	-	-
tirapazamine (SR259075)	Phase 3	Head and Neck Neoplasms	-	-
efanesoctocog alfa (BIVV001)	Phase 3	Hemophilia A	-	-
Insulin glulisine (HMR1964)	Phase 3	Diabetes, Type I	-	-
Belumosudil	Phase 3	Chronic Graft Versus Host Disease	-	-
Aldurazyme (Recombinant Human Alpha-L-Iduronidase)	Phase 3	Mucopolysaccharidosis I	-	-
Insulin glargine new formulation (HOE901)	Phase 3	Type 2 Diabetes Mellitus	-	-
Lactic acid (Dermacyd Femina Delicata)	Phase 3	Hygiene	-	-
Myozyme	Phase 3	Pompe Disease (Late-onset)	-	-
Topical tacrolimus or pimecrolimus	Phase 3	Dermatitis Atopic	-	-
INSULIN GLARGINE/LIXISENATIDE HOE901/AVE0010	Phase 3	Type 2 Diabetes Mellitus	-	-
sutimlimab	Phase 3	Cold Agglutinin Disease	-	-
Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine	Phase 3	Diphtheria	-	-
Ramipril	Phase 3	Myocardial Ischemia	-	-
GZ/SAR402671	Phase 2	Fabry Disease	-	-
XRP0038 (NV1FGF)	Phase 2	Peripheral Arterial Disease	-	-
CYD dengue vaccine serotypes (1, 2, 3, 4).	Phase 2	Dengue Virus	-	-
G-CSF Plus Plerixafor	Phase 2	Hodgkin's Disease	-	-
SAR443122	Phase 2	Colitis Ulcerative	-	-
RSV vaccine candidate	Phase 2	Respiratory Syncytial Virus Infection	-	-
SAR441344 IV	Phase 2	Systemic Lupus Erythematosus	-	-
Belumosudil 200 mg QD	Phase 2	Chronic Graft-versus-host-disease	-	-
A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®)	Phase 2	Meningitis	-	-
Oxaliplatin, Paclitaxel	Phase 2	Neoplasms, Germ Cell and Embryonal	-	-
oxaliplatine / gemcitabine / Vinorelbine	Phase 2	Non Small Cell Lung Cancer	-	-
Cabazitaxel XRP6258	Phase 2	Prostate Cancer	-	-
Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate	Phase 2	Meningitis	-	-
INIPARIB + irinotecan	Phase 2	Estrogen Receptor Negative (ER-Negative) Breast Cancer	-	-
Sevelamer hydrochloride	Phase 2	Chronic Kidney Disease	-	-
Fludarabine Phosphate (Fludara)	Phase 2	Lymphoma	-	-
HP184	Phase 2	Spinal Cord Injury	-	-
Thymoglobulin	Phase 2	Liver Dysfunction	-	-
Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus	Phase 2	Dengue Fever	-	-
Inactivated types 1, 2, and 3 poliovirus, D antigens	Phase 2	Poliomyelitis	-	-
AVE1625	Phase 2	Alzheimer Disease	-	-
SAR100842	Phase 2	Systemic Sclerosis	-	-
SAR445877	Phase 2	Solid Tumor	-	-
Clostridium difficile toxoid vaccine with adjuvant	Phase 2	Diarrhea	-	-
Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus	Phase 2	Dengue	-	-
Monovalent Subvirion A/H1N1 Influenza vaccine	Phase 2	Influenza	-	-
Artefenomel (OZ439)	Phase 2	Plasmodium Falciparum Infection	-	-
Docetaxel (Taxotere®)	Phase 2	Ovarian Cancer	-	-
FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid	Phase 2	Colorectal	-	-
Polysaccharide Diphtheria Toxoid Conjugate Vaccine	Phase 2	Meningococcal Meningitis	-	-
SSR150106	Phase 2	Rheumatoid Arthritis	-	-
A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine	Phase 2	Influenza	-	-
Glatiramer Acetate (GA)	Phase 2	Multiple Sclerosis	-	-
SAR444200	Phase 2	Neoplasm	-	-
SAR161271	Phase 2	Type 1 Diabetes Mellitus	-	-
docetaxel and carboplatin	Phase 2	Lung Neoplasms	-	-
Chlamydia mRNA Vaccine	Phase 2	Chlamydia Trachomatis Immunization	-	-
Inactivated, split-virion influenza virus	Phase 2	Influenza	-	-
Pneumococcal Conjugate Vaccine formulation 1	Phase 2	Pneumococcal Immunisation	-	-
surinabant (SR147778)	Phase 2	Smoking Cessation	-	-
Fixed-dose combination of capecitabine and cyclophosphamide SAR439281	Phase 2	Breast Cancer Metastatic	-	-
XL147 (SAR245408)	Phase 2	Endometrial Cancer	-	-
Rasburicase (SR29142)	Phase 2	Hyperuricemia	-	-
Allogeneic DCs and Autologous RCC Tumor Derived Cells	Phase 2	Carcinoma, Renal Cell	-	-
QIV-HD by IM	Phase 2	Influenza	-	-
Interferon-β-1	Phase 2	Multiple Sclerosis	-	-
Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate	Phase 2	Meningitis	-	-
Alemtuzumab plus Fludarabine	Phase 2	Leukemia, Lymphocytic, Chronic, B-Cell	-	-
Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine	Phase 2	Meningitis	-	-
Brivekimig	Phase 2	Hidradenitis Suppurativa	-	-
Panblok + MF59 Dose 1	Phase 2	Influenza	-	-
XL765 (SAR245409)	Phase 2	Breast Cancer	-	-
AVE5530	Phase 2	Hypercholesterolemia	-	-
SAR3419	Phase 2	Diffuse Large B-Cell Lymphoma	-	-
Inactivated Poliomyelitis vaccine (IMOVAX)	Phase 2	Poliomyelitis	-	-
HOE140 Icatibant	Phase 2	Joint Disease	-	-
SAR407899	Phase 2	Erectile Dysfunction	-	-
High-Dose Trivalent Inactivated Influenza Vaccine	Phase 2	Influenza	-	-
Quadrivalent Influenza mRNA Vaccine MRT5407	Phase 2	Influenza Immunization	-	-
Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)	Phase 2	Influenza	-	-
Iniparib	Phase 2	Primary Peritoneal Cancer	-	-
ALX-0081	Phase 2	Unstable Angina	-	-
Celivarone	Phase 2	Arrhythmia Prophylaxis	-	-
ataciguat (HMR1766)	Phase 2	Intermittent Claudication	-	-
Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28)	Phase 2	Japanese Encephalitis	-	-
Acne mRNA vaccine	Phase 2	Acne	-	-
Dupilumab SAR231893/REGN668	Phase 2	Asthma	-	-
PRN473 (SAR444727)	Phase 2	Atopic Dermatitis	-	-
Docetaxel, cisplatin and 5-FU treatment followed by concomitant cisplatin, 5-FU and radiotherapy	Phase 2	Head and Neck Neoplasms	-	-
CYD Dengue Vaccine (5 dose formulation)	Phase 2	Dengue Fever	-	-
ferroquine (SSR97193)	Phase 2	Malaria	-	-
Pneumococcal Conjugate Vaccine - formulation 1-SP0202-IIb	Phase 2	Pneumococcal Immunization	-	-
Clostridium difficile Toxoid Vaccine	Phase 2	Clostridium Difficile Infection	-	-
plerixafor GZ316455	Phase 2	Multiple Myeloma	-	-
Vandetanib 300mg	Phase 2	Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma	-	-
teplizumab 1 mg/mL	Phase 2	Diabetes Mellitus, Type 1	-	-
MRrhTSH	Phase 2	Multinodular Goiter	-	-
ALX-0171	Phase 2	Respiratory Syncytial Virus Infection	-	-
Docetaxel and cisplatin followed by gemcitabine	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
SAR444336	Phase 2	Microscopic Colitis	-	-
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine	Phase 2	Meningitis	-	-
Live attenuated Japanese encephalitis virus, then ChimeriVax diluent	Phase 2	Encephalitis	-	-
SAR245408	Phase 2	Neoplasm Malignant	-	-
SSR149744C	Phase 2	Arrhythmia	-	-
SR57667B	Phase 2	Alzheimer Disease	-	-
SAR446597	Phase 2	Geographic Atrophy	-	-
DOCETAXEL(XRP6976)	Phase 2	Head and Neck Neoplasms	-	-
SL77.0499-10 (alfuzosin hydrochloride)	Phase 2	Benign Prostatic Hyperplasia	-	-
SAR425899	Phase 2	Type 2 Diabetes Mellitus	-	-
SAR447537	Phase 2	Alpha 1-Antitrypsin Deficiency	-	-
SAR441566	Phase 2	Crohn's Disease	-	-
SAR441344	Phase 2	Sjögren's Syndrome	-	-
BSI-201	Phase 2	Ovarian Cancer	-	-
Fabrazyme (agalsidase beta)	Phase 2	Fabry Disease	-	-
Influenza virus vaccine - cell based (2007-2008 Formulation)	Phase 2	Influenza	-	-
SSR240600C	Phase 2	Overactive Bladder	-	-
ChimeriVax-WN02 vaccine	Phase 2	West Nile Fever	-	-
Best Supportive Care	Phase 2	Carcinoma, Hepatocellular	-	-
Chimeric dengue serotype (1, 2, 3, 4)	Phase 2	Dengue	-	-
clofarabine	Phase 2	Acute Lymphoblastic Leukemia	-	-
Live attenuated Japanese encephalitis virus; Yellow fever virus	Phase 2	Japanese Encephalitis	-	-
larotaxel	Phase 2	Breast Cancer	-	-
Isatuximab	Phase 2	Plasma Cell Myeloma Refractory	-	-
ZD6474	Phase 2	Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line	-	-
ALX-0061	Phase 2	Lupus Erythematosus, Systemic	-	-
VEGF-receptor tyrosine kinase (KDR)	Phase 2	Multiple Myeloma	-	-
High-dose quadrivalent influenza virus vaccine	Phase 2	Influenza	-	-
Swine A/H1N1 influenza vaccine (split virion, inactivated)	Phase 2	Influenza	-	-
ATN-103 10 mg q4wks	Phase 2	Rheumatoid Arthritis	-	-
A/H5N1 inactivated, split-virion influenza virus	Phase 2	Influenza	-	-
Belumosudil (KD025)	Phase 2	Graft vs Host Disease	-	-
SSR411298	Phase 2	Major Depressive Disorder	-	-
Quadrivalent Influenza mRNA Vaccine MRT5421	Phase 2	Influenza Immunization	-	-
Live attenuated Japanese encephalitis virus	Phase 2	Japanese Encephalitis	-	-
GT160-246	Phase 2	Clostridium Difficile-Associated Diarrhea	-	-
Mitoguazone	Phase 2	Lymphoma, Non-Hodgkin	-	-
FOLFIRI	Phase 2	Colorectal Cancer	-	-
ATN-103	Phase 2	Rheumatoid Arthritis	-	-
SAR446268	Phase 2	Myotonic Dystrophy	-	-
RSV vaccine formulation 1	Phase 2	Respiratory Syncytial Virus Infection	-	-
ZD1839	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
Sotagliflozin (SAR439954)	Phase 2	Diabetes Mellitus	-	-
High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)	Phase 2	Influenza	-	-
Vasopressin V2 Receptor Antagonist	Phase 2	Chronic Heart Failure	-	-
Cemiplimab REGN2810	Phase 2	Plasma Cell Myeloma	-	-
IIV-HD	Phase 2	COVID-19 Immunization	-	-
GZ389988	Phase 2	Osteoarthritis	-	-
satavaptan (SR121463B)	Phase 2	Ascites	-	-
Yellow fever vaccine (produced on serum-free Vero cells)	Phase 2	Yellow Fever	-	-
Pandemic flu H5 HA mRNA SD2 vaccine	Phase 2	Pandemic Influenza Immunization	-	-
Docetaxel and Gemcitabine	Phase 2	Non-small Cell Lung Cancer	-	-
Trilostane	Phase 2	Prostate Cancer	-	-
fresolimumab	Phase 2	Primary Focal Segmental Glomerulosclerosis	-	-
Fetal porcine cells, Neurocell-PD	Phase 2	Parkinson's Disease	-	-
SAR156597	Phase 2	Idiopathic Pulmonary Fibrosis	-	-
Docetaxel + CDDP	Phase 2	Carcinoma, Squamous Cell	-	-
unfractionated heparin	Phase 2	Coronary Disease	-	-
Inactivated, split-virion, influenza vaccine	Phase 2	Influenza	-	-
Split, Inactivated, Trivalent Influenza Vaccine	Phase 2	Orthomyxoviridae Infection	-	-
Tesevatinib	Phase 2	Autosomal Dominant Polycystic Kidney	-	-
ALX-0171 3.0 mg/kg	Phase 2	Respiratory Syncytial Virus Lower Respiratory Tract Infection	-	-
RIV (recombinant influenza vaccine)	Phase 2	COVID-19 Immunization	-	-
Isatuximab intravenous (IV)	Phase 2	Plasma Cell Myeloma	-	-
SL650472, Clopidogrel	Phase 2	Intermittent Claudication	-	-
AVE0657	Phase 2	Sleep Apnea, Obstructive	-	-
Quadrivalent Inactivated Influenza High Dose	Phase 2	Influenza Immunization	-	-
Short-Acting Beta Agonists (SABA)	Phase 2	Asthma	-	-
Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC	Phase 2	Diphtheria	-	-
Zemaira	Phase 2	Alpha 1-Antitrypsin Deficiency	-	-
Oxaliplatin, capecitabine	Phase 2	Rectal Neoplasms	-	-
SAR292833	Phase 2	Neuropathic Pain	-	-
Vandetanib (ZD6474)	Phase 2	Advanced Breast Cancer	-	-
Liraglutide	Phase 2	Type 2 Diabetes Mellitus	-	-
fluoropyrimidine	Phase 2	Colorectal Cancer	-	-
Purified Vero Rabies Vaccine (VRVg) - Serum Free	Phase 2	Rabies	-	-
Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)	Phase 2	Esophageal Neoplasms	-	-
A/H5N1 Inactivated, split-virion pandemic influenza vaccine	Phase 2	Influenza	-	-
ICS/LABA therapy	Phase 2	Asthma	-	-
Dexamethasone	Phase 2	Hematological Malignancy	-	-
Laronidase	Phase 2	Mucopolysaccharidosis I	-	-
PRV-015	Phase 2	Celiac Disease	-	-
(ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis	Phase 2	Pertussis	-	-
Carboplatin	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
CYD Dengue Vaccine (5-dose formulation)	Phase 2	Dengue Fever	-	-
ChimeriVax-WN02 Low Dose	Phase 2	West Nile Fever	-	-
Enteric coated sevelamer	Phase 2	Hypercholesterolemia	-	-
Influenza virus vaccine 2009-2010 formulation	Phase 2	Influenza	-	-
Inactivated rabies virus vaccine	Phase 2	Dengue Virus	-	-
Pentavalent Meningococcal ABCYW vaccine	Phase 2	Meningococcal Immunization	-	-
Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus	Phase 2	Dengue	-	-
Rilzabrutinib dose 1	Phase 2	Graves' Disease	-	-
bsi-201 plus temozolomide	Phase 2	Glioblastoma	-	-
ILX651	Phase 2	Melanoma	-	-
recombinant human acid alpha-glucosidase (rhGAA)	Phase 2	Pompe Disease	-	-
Fitusiran (SAR439774)	Phase 2	Hemophilia A	-	-
RSV/hMPV vaccine candidate Dose L	Phase 2	Respiratory Syncytial Virus Infection	-	-
Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)	Phase 2	Influenza	-	-
Deferitrin (GT56-252)	Phase 2	Beta-Thalassemia	-	-
AVE2268	Phase 2	Type 2 Diabetes Mellitus	-	-
VRVg 2	Phase 2	Rabies Virus	-	-
Insulin glargine /lixisenatide Fixed Ratio Combination	Phase 2	Type 2 Diabetes Mellitus	-	-
Olipudase alfa	Phase 2	Niemann-Pick Disease	-	-
Polysaccharide Diphtheria Conjugate Vaccine	Phase 2	Meningitis	-	-
Smallpox vaccine, LISTER strain, from chick embryo cells	Phase 2	Smallpox	-	-
Tdap vaccine	Phase 2	Dermatitis Atopic	-	-
Blood draw for the laboratory assessment	Phase 2	Usher's Syndrome	-	-
oxaliplatin, 5 FU	Phase 2	Endometrial Cancer	-	-
Etoposide	Phase 2	Acute Lymphoblastic Leukemia	-	-
CYD Dengue Vaccine Serotypes 1, 2, 3, and 4	Phase 2	Dengue Virus	-	-
docetaxel and cisplatin	Phase 2	Ovarian Neoplasms	-	-
Genz-644470	Phase 2	Kidney Failure, Chronic	-	-
statins	Phase 2	Hypercholesterolaemia	-	-
Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA)	Phase 2	Influenza	-	-
Hexadecasaccharide (SR123781A)	Phase 2	Coronary Atherosclerosis	-	-
VASOPRESSIN V1B RECEPTOR ANTAGONIST (SSR149415)	Phase 2	Major Depressive Disorder	-	-
Bicalutamide	Phase 2	Prostate Cancer	-	-
Otamixaban (XRP0673)	Phase 2	Angioplasty, Transluminal, Percutaneous Coronary	-	-
SAR442168	Phase 2	Relapsing Multiple Sclerosis	-	-
Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV	Phase 2	Pertussis	-	-
AVE1625 B	Phase 2	Obesity	-	-
Bivalent CYD-1,3 Dengue (Vero) + Bivalent CYD-2,4 Dengue (Vero)	Phase 2	Dengue Virus	-	-
ZD6474 (vandetanib) 100mg	Phase 2	Non Small Cell Lung Carcinoma	-	-
alvocidib	Phase 2	Leukemia, Lymphocytic, Chronic	-	-
Zactima (vandetanib)	Phase 2	Prostate Cancer	-	-
Advate (Low Dose)	Phase 2	Hemophilia A	-	-
SSR180575	Phase 2	Diabetic Neuropathies	-	-
Itepekimab SAR440340	Phase 2	Chronic Obstructive Pulmonary Disease	-	-
ZD6474, Vandetanib	Phase 2	Non Small Cell Lung Cancer	-	-
SAR444836	Phase 2	Phenylketonuria	-	-
GZ402665	Phase 2	Sphingomyelin Lipidosis	-	-
Quadrivalent Influenza mRNA Vaccine MRT5413	Phase 2	Influenza Immunization	-	-
Isatuximab SC-OBDS	Phase 2	Plasma Cell Myeloma Refractory	-	-
SAR402663	Phase 2	Neovascular Age-related Macular Degeneration	-	-
Sargramostim (Leukine)	Phase 2	Crohn Disease	-	-
Menomune®: A, C, Y, W-135 Meningococcal Polysaccharide	Phase 2	Meningococcal Infections	-	-
Amisulpride	Phase 2	Bipolar Disorder	-	-
Haemophilus Influenzae Type b (Hib) vaccine	Phase 2	Meningitis	-	-
Yellow fever vaccine	Phase 2	Yellow Fever	-	-
G-CSF and plerixafor	Phase 2	Lymphoma, Non-Hodgkin	-	-
Yellow Fever	Phase 2	Dengue	-	-
SR31747A	Phase 2	Prostatic Neoplasm	-	-
Interferon-β	Phase 2	Multiple Sclerosis	-	-
BIVV020 (SAR445088)	Phase 2	Transplant Rejection	-	-
CoV2 preS dTM-AF03 (low-dose)	Phase 2	COVID-19 (Healthy Volunteers)	-	-
Menomune®: A, C, Y, W 135 Meningococcal Polysaccharide	Phase 2	Meningitis	-	-
SAR125844	Phase 2	Neoplasm Malignant	-	-
aminopterin	Phase 2	Leukemia	-	-
SAR445088 (IV)	Phase 2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy	-	-
Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1	Phase 2	Influenza	-	-
anti-thymocyte globulin	Phase 2	Myelodysplastic Syndromes	-	-
Long term follow up in all patients who received SAR422459 in previous study TDU13583	Phase 2	Stargardt's Disease	-	-
sevelamer carbonate, sevelamer hydrochloride	Phase 2	Chronic Kidney Disease	-	-
Fluzone: Influenza virus vaccine	Phase 2	Influenza	-	-
Meningococcal Polysaccharide Diphtheria Protein Conjugate (Menactra®)	Phase 2	Meningitis	-	-
THOR-707	Phase 2	Oesophageal Squamous Cell Carcinoma	-	-
docetaxel and cisplatin followed by concurrent chemoradiotherapy with docetaxel and cisplatin + radiotherapy	Phase 2	Lung Neoplasms	-	-
Investigational hMPV/RSV vaccine	Phase 2	Human Metapneumovirus Immunization	-	-
Glucocorticoids	Phase 2	Immunoglobulin G4 Related Disease	-	-
SAR445399	Phase 2	Hidradenitis Suppurativa	-	-
Oxaliplatin, 5-Fluorouracil	Phase 2	Stomach Neoplasms	-	-
Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]	Phase 2	Renal Transplantation	-	-
SAR113945	Phase 2	Knee Osteoarthritis	-	-
XRP9881	Phase 2	Breast Cancer	-	-
Inactivated influenza vaccine (split virion)	Phase 2	Influenza	-	-
IRBESARTAN (SR47436)	Phase 2	Hypertension	-	-
Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1	Phase 2	Tetanus	-	-
Purified Vero Rabies Vaccine Serum Free (VRVg)	Phase 2	Rabies	-	-
tolterodine	Phase 2	Overactive Bladder	-	-
Plerixafor (AMD3100)	Phase 2	Lymphoma	-	-
Inactivated influenza vaccine (split virion) NH 2007-2008 formulation	Phase 2	Influenza	-	-
SAR440340	Phase 2	Asthma	-	-
Purified Vero Rabies Vaccine (VRVg)	Phase 2	Rabies	-	-
RSV vaccine candiate formulation 1	Phase 2	Respiratory Syncytial Virus Immunization	-	-
SAR110894	Phase 2	Dementia Alzheimer's Type	-	-
Oxaliplatin, capecitabine, radiotherapy	Phase 2	Rectal Neoplasms	-	-
Tetravalent CYD Dengue Vaccine , 5555 formulation	Phase 2	Dengue Fever	-	-
Meningococcal Polysaccharide (A, C, Y, and W 135) Tetanus Protein Conjugate Vaccine	Phase 2	Meningitis	-	-
SSR125543	Phase 2	Major Depression	-	-
Pandemic flu H5 mRNA vaccine	Phase 2	Influenza Immunization	-	-
ChimeriVax™-JE vaccine	Phase 2	Japanese Encephalitis	-	-
Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis	Phase 2	Dengue	-	-
Influenza virus (split virion, inactivated) vaccine	Phase 2	Influenza	-	-
MVA Smallpox vaccine	Phase 2	Smallpox	-	-
Nerispirdine	Phase 2	Multiple Sclerosis	-	-
2009-2010 Trivalent Influenza Virus Vaccine	Phase 2	Influenza	-	-
SAR442970	Phase 2	Crohn's Disease	-	-
Docetaxel + Oxaliplatin	Phase 2	Stomach Neoplasms	-	-
MenABCYW conjugate vaccine	Phase 2	Meningococcal Immunisation	-	-
S-1	Phase 2	Gastric Cancer	-	-
Clostridium difficile toxoids A and B (Low-dose with adjuvant)	Phase 2	Clostridium Difficile Infection	-	-
Any Inhaled Corticosteroids as prescribed by treating physician as standard of care	Phase 2	Chronic Obstructive Pulmonary Disease	-	-
Alglucosidase alfa (GZ419829)	Phase 2	Glycogen Storage Disease Type II-Pompe's Disease	-	-
PRN1008	Phase 2	Pemphigus Vulgaris	-	-
Nolpitantium besylate	Phase 2	Ulcerative Colitis	-	-
SSR149415	Phase 2	Depressive Disorder	-	-
CABAZITAXEL (XRP6258)	Phase 2	Prostatic Neoplasms	-	-
SAR445088 (BIVV020)	Phase 2	Immune Thrombocytopenia (ITP)	-	-
Quadrivalent Influenza mRNA Vaccine MRT5410	Phase 2	Influenza Immunization	-	-
Influenza virus vaccine (2004-2005 Formulation)	Phase 2	Influenza	-	-
Split virion, inactivated Influenza vaccine	Phase 2	Influenza	-	-
Topotecan	Phase 2	Small Cell Lung Cancer	-	-
gemcitabine plus carboplatin plus BSI-201	Phase 2	Triple Negative Breast Cancer	-	-
ARD6562, Docetaxel	Phase 2	Prostatic Neoplasms	-	-
Ad2/HIF-1α/VP16	Phase 2	Intermittent Claudication	-	-
SR147778	Phase 2	Obesity	-	-

Meningitis

3 drugs in this indication

Diphtheria

2 drugs in this indication

Obesity

2 drugs in this indication

Hygiene

2 drugs in this indication

Hemophilia

2 drugs in this indication

Yellow Fever Immunization

2 drugs in this indication

Type 2 Diabetes Mellitus

2 drugs in this indication

Healthy Volunteers (Meningococcal Infection)

2 drugs in this indication

Stomach Neoplasms

1 drug in this indication

Hemophilia A

1 drug in this indication

Dengue Virus

1 drug in this indication

Acute Urinary Retention

1 drug in this indication

Alzheimer Disease

1 drug in this indication

Sleep Initiation and Maintenance Disorders

1 drug in this indication

Peripheral Arterial Disease

1 drug in this indication

Influenza

1 drug in this indication

Ulcerative Colitis

1 drug in this indication

Dengue

1 drug in this indication

Colitis Ulcerative

1 drug in this indication

Pompe Disease (Late-onset)

1 drug in this indication

Depressive Disorder

1 drug in this indication

Non Small Cell Lung Cancer

1 drug in this indication

Breast Neoplasms

1 drug in this indication

Systemic Lupus Erythematosus

1 drug in this indication

Carcinoma, Hepatocellular

1 drug in this indication

RSV Immunisation

1 drug in this indication

Seasonal Allergic Rhinitis

1 drug in this indication

Chronic Graft-versus-host-disease

1 drug in this indication

Hypercholesterolemia

1 drug in this indication

Hodgkin's Disease

1 drug in this indication

Respiratory Syncytial Virus Infection

1 drug in this indication

Neoplasms, Germ Cell and Embryonal

1 drug in this indication

Meningococcal Meningitis

1 drug in this indication

Prostate Cancer

1 drug in this indication

Polyneuropathy, Inflammatory Demyelinating, Chronic

1 drug in this indication

Chronic Kidney Disease

1 drug in this indication

Lymphoma

1 drug in this indication

Hemophilia B

1 drug in this indication

Spinal Cord Injury

1 drug in this indication

Immune Thrombocytopenia

1 drug in this indication

Rabies

1 drug in this indication

Diabetes Mellitus, Type 1

1 drug in this indication

Lung Cancer

1 drug in this indication

Glycogen Storage Disease Type II

1 drug in this indication

Estrogen Receptor Negative (ER-Negative) Breast Cancer

1 drug in this indication

Rheumatoid Arthritis

1 drug in this indication

Meningococcal Immunisation (Healthy Volunteers)

1 drug in this indication

Pertussis

1 drug in this indication

Liver Dysfunction

1 drug in this indication

Dengue Fever

1 drug in this indication

Neurodermatitis

1 drug in this indication

Poliomyelitis

1 drug in this indication

Atrial Fibrillation

1 drug in this indication

Major Depressive Disorders

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Regulatory Approvals

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Sanofi

Market Overview

SNY News

Catalyst Timeline

Pandemic flu H5 mRNA vaccine Phase 2 Results Expected

Sarilumab SAR153191 (REGN88) Phase 2 Results Expected

IIV-HD Phase 2 Results Expected

RIV (recombinant influenza vaccine) Phase 2 Results Expected

Bortezomib Phase 3 Results Expected

Isatuximab SAR650984 Phase 3 Results Expected

Pipeline & FDA Submissions

Competitive Positions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals